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Introduction
Despite the advances in preventing and controlling non-
infectious diseases in recent decades, the incidence 
and prevalence of these diseases have increased 
dramatically [1]. Cancer is the second cause of death 
in most countries after cardiovascular diseases  [2-6]. 
There were 24.5  million new cancer cases and 9.6 
million cancer deaths worldwide in 2017, and led to 
233.5 million Disability-Adjusted Life Year (DALYs), 
of which 3% came from Years lived with disability 
(YLDs) and 97% came from Years of Life Lost (YLLs). 
Globally, the odds of developing cancer in lifetime 
were 33% for men and 25% for women. Between 
2007 and 2017, the Age-Standardized Incidence Rate 
(ASIR) for all cancers has increasing trend, but Age-
Standardized Mortality Rate(ASMR) has decreasing 
trend [7]. Liver is an important body organ that plays an 
key role in the detoxification, excretion of waste, and 
the metabolism of glucose and fats  [8]. Liver cancer 
(LC) is ranked seventh among cancers in terms of the 
incidence; and since most cases of LC are diagnosed 
at advanced stages of disease, its fatality is high, so 
that this cancer is ranked fourth among other types of 
cancers in terms of the mortality  [9]. Globally, there 
were 953000 new cases and 819 000 deaths of LC in 
2017. LC led to 20,800,000  DALYs in 2017, which 
1% coming from YLDs and 99% coming from YLLs. 
Generally, LC was more common in men, so lifetime 
odds of developing LC for men were 1 in 42 and for 
women 1 in 118. Population growth and population 
aging were the main causes of the increase of LC from 
705000 cases in 2007 to 953000 cases in 2017  [7]. 
The most important risk factors associated with the 
incidence of LC are diagnosed, and most of them can 
be prevented and altered at the individual and social 
levels. Therefore, the incidence of LC and ultimately 
the rate of its mortality can be reduced in societies by 
taking appropriate measures [10]. 
LC can be categorized into three main forms with 
different risk factors associated with each of them. 
Hepatocellular carcinoma (HCC) is the most 
important LC form which is caused by the following 
cases: chronic infection with hepatitis B and C 
viruses; food contamination with aflatoxins; alcoholic 
cirrhosis; smoking, diabetes, overweight and obesity. 
Cholangiocarcinoma is the second most important LC 
form which is mainly caused by the following factors: 
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infestation with liver flukes, Opistorchis viverrini and 
Clonorchis sinensis. Angiosarcoma is a very rare type 
of LC occurring in exposure to Vinyl chloride [11]. 
In the world, the ASIR of LC is 16 per 100,000 men 
and 6 per 100,000 women. The ASIR of LC in less 
developed countries is higher than developed countries 
(12 versus 5.4 per 100,000) [12]. Since the LC is a 
very high prevalent cancer and has high mortality 
due to the late diagnosis, it is considered to be a 
major health problem which imposes a large burden 
in term DALYs (YLL and YLD) on countries. Due 
to the high importance of this cancer, various studies 
have been conducted on estimating its burden on 
developed countries  [11, 13]. Nevertheless, there are 
a few studies on distribution of LC at the international 
level [14]. Since obtaining the appropriate information 
to properly understand distribution of any disease in 
terms of person, place, and time is the first and most 
important necessity for appropriate measures and 
interventions to reduce the incidence and mortality 
of any disease, the present study was conducted with 
the aim to investigate the international distribution of 
the incidence and mortality of LC in 2018 based on 
various socio-economic and political divisions in the 
world. In addition, present study predicts the trends of 
incidence and mortality of LC during 2018 to 2040 in 
worldwide. 
Materials and methods 
In the present study, we extracted data on the 
incidence and mortality rate of LC in 184 countries 
from the International Agency for Research on Cancer 
(IARC) (Project GLOBOCAN, 2018). GLOBOCAN 
is a database of various types of cancers created 
by World Health Organization (WHO)  [15, 16]. It 
covers information on the number, raw rates, and age 
standardization of cancer incidence, and mortality 
for different regions and countries. Currently, the 
available data in GLOBOCAN is known as one of the 
newest international databases on the cancer. Based 
on the data of GLOBOCAN project, it is possible to 
investigate and compare the incidence and mortality 
of cancer based on the type of cancer, age and gender 
groups for different regions of the world. 
The present study categorized and presented the 
information on the Age-Standardized Incidence Rate 
(ASIR) and Age Standardized Mortality Rate (ASMR) 
of LC based on the continents (Africa, Latin America and 
Caribbean, Northern America, Europe, Oceania, Asia), 
income levels(high income, upper middle income, low 
middle income, and low income),human development 
index(HDI) (very high, high, medium, low, China and 
India),WHO regions (Africa region (AFRO), Americas 
region (PAHO), East Mediterranean region (EMRO), 
Europe region (EURO), South-East Asia region 
(SEARO) and Western Pacific region (WPRO)), and 
World regions(Australia and New Zealand, Caribbean, 
central America, central and eastern Europe, eastern 
Africa, eastern Asia, Melanesia, Micronesia, middle 
Africa, north America, northern Africa, northern 
Europe, Polynesia, south America, south-central Asia, 
south-eastern Asia, southern Africa, southern Europe, 
western Africa, western Asia, and western Europe). 
Human Development Index (HDI)
Human Development Index (HDI) is a summary 
measure of average achievement in key dimensions of 
human development: life expectancy, education, and 
per capita income. The HDI is the geometric mean of 
normalized indices for each of the three dimensions 
with rang from 0 to 1 [17]. 
Statistical analysis
We provided the information about the incidence and 
mortality of LC based on the number, raw rates and 
the Age-Standardized rates in 2018. We also expressed 
raw and standardized rates of incidence and mortality 
per 100,000 people. Geographical distribution map 
was prepared for the incidence and mortality of 
this disease based on the Age-Standardized rates. 
In GLOBOCAN project, predicting the number of 
incidence and mortality of LC in 2020, 2025, 2030, 
2035 and 2040 is calculated by multiplying the age-
specific incidence rates estimated for 2018, by the 
corresponding anticipated population for 2020, 2025, 
2030, 2035 and 2040  [9]. Detailed descriptions of 
applied methods are presented in previous reports [11-
14]. In the current report; we used Pearson correlation 
method in order to assess the correlation between 
ASIR and ASMR of LC. Statistical significance was 
considered as P < 0.05. All P-values reported in this 
study are two-sided. Also, statistical analyses were 
performed using SPSS (Version 16.0, SPSS Inc.).
Results 
The ASIR and ASMR of LC in the world 
In 2018, 841,080 new cases of LC were diagnosed 
worldwide. Of them 596,574 (70.92%) cases occurred 
in men and 244506 (29.08%) in women. In general, 
the ASIR of LC was equal to 9.3 (13.9 in men and 4.9 
in women). The sex ratio (men to women ratio) of the 
newly diagnosed LC was equal to 2.43 (Fig. 1). 
There were also 781,631 deaths from LC during this 
year. Of them, 548,375 (70.15%) cases occurred in 
men and 233,256 (29.85%) in women. In general, the 
ASMR of LC was equal to 8.5 (12.7 in men and 4.6 
in women). The sex ratio of the mortality of LC was 
equal to 2.35 (Fig. 2).
The ASIR and ASMR of LC based on  
the continents
The ASIR of LC was equal to 6.6 (10.1 in men, and 
3.4 in women) in North America, 5.1 (8 in men, and 
2.7 in women) in Europe, 6.9 (10.1 in men and 3.7 
in women) in Oceania, 11.4 (17.1 in men and 5.9 in 
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women) in Asia, 5 (6.1 in men and 4.1 in women) in 
Latin America and Caribbean, and 8.4 (12 in men and 
5.3 in women) in Africa. Of the total number of this 
disease in the world, the highest proportion occurred 
in Asia and the lowest proportion in Oceania, so that 
72.47% of cases occurred in Asia, 9.8% in Europe, 
4.97% in North America, 4.56% in Latin America and 
Caribbean, 7.73% in Africa and 0.47% in Oceania 
(Tab. I, Figs. 1-4). In addition, numbers, crude rate and 
ASIR of LC in worldwide countries are visible in the 
Supplementary data (Tab. SI).
The ASMR of LC was equal to 4.8 (7.1 in men, and 
2.8 in women) in North America, 4.4 (6.8 in men, and 
2.4 in women) in Europe, 10.5 (15.8 in men and 5.5 in 
women) in Asia, 5.8 (8.3 in men and 3.4 in women) in 
Oceania, 4.8 (7.1 in men and 2.8 in women) in Latin 
America and Caribbean, and 8.3 (11.9 in men and 5.2 
in women) in Africa. Of the total number of deaths 
 
Figure 1: Distribution of new LC cases worldwide in 2018 
 
Figure 2: Distribution of LC mortality worldwide in 2018
Fig. 1. Distribution of new LC cases worldwide in 2018.
Fig. 2. Distribution of LC mortality worldwide in 2018.
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Tab. I. The age-standardized incidence rate of liver cancer in different regions of the world in 2018.
Population
All Men Women
Numbers Crude rate
ASR
(W) Numbers
Crude
rate
ASR
(W) Numbers
Crude
rate
ASR
(W)
World 841,080 11 9.3 596,574 15.5 13.9 244,506 6.5 4.9
WHO 
regions
WHO Africa  
region (AFRO) 37,036 3.4 6 23,719 4.4 8.1 13,317 2.5 4.1
WHO Americas  
region (PAHO) 80,251 7.9 5.6 50,684 10.1 7.8 29,567 5.8 3.7
WHO East 
Mediterranean  
region (EMRO)
39,415 5.7 7.9 26,936 7.5 10.7 12,479 3.7 5
WHO Europe  
region (EURO) 91,988 10 5.1 61,546 13.7 7.9 30,442 6.4 2.8
WHO South-East Asia 
region (SEARO) 84,733 4.3 4.5 59,783 5.9 6.5 24,950 2.6 2.6
WHO Western Pacific 
region (WPRO) 507,501 26.2 17.4 373,794 37.9 26.4 133,707 14.1 8.5
Continents
Africa 64,779 5 8.4 43,530 6.8 12 21,249 3.3 5.3
Asia 609,596 13.4 11.4 443,744 19.1 17.1 165,852 7.5 5.9
Europe 82,466 11.1 5.1 55,825 15.5 8 26,641 6.9 2.7
Latin America  
and the Caribbean 38,400 5.9 5 20,784 6.5 6.1 17,616 5.3 4.1
North America 41,851 11.5 6.6 29,900 16.6 10.1 11,951 6.5 3.4
Oceania 3,988 9.7 6.9 2,791 13.5 10.1 1 197 5.8 3.7
Human 
Development 
Index (HDI)
China 392,868 27.6 18.3 292,898 40 27.6 99,970 14.5 9
High HDI 76,109 19.1 13.8 46,301 27.2 20.8 29,808 10.7 7.2
India 27,670 2 2.2 18,807 2.7 3.1 8,863 1.4 1.4
Low HDI 33,447 3.3 6 21,138 4.1 7.9 12,309 2.4 4.3
Medium HDI 115,604 5.2 5.9 82,796 7.2 8.6 32,808 3.1 3.3
Very high HDI 195,092 14.1 6.9 134,426 19.6 10.6 60,666 8.6 3.5
Income 
levels
High income 167,606 13.8 6.6 116,876 19.3 10.2 50,730 8.3 3.3
Low income 29,774 4 6.9 19,080 5.1 9.4 10,694 2.8 4.6
Low middle income 148,420 4.9 5.7 104,493 6.8 8.2 43,927 3 3.2
Upper middle income 480,356 18.3 13.4 345,927 26.1 20.2 134,429 10.3 7
World 
regions
Australia  
and New Zealand 2,921 9.9 5.7 2,115 14.4 8.8 806 5.4 2.7
Caribbean 2,923 6.6 5 1,706 7.8 6.3 1,217 5.5 3.8
Central America 11,229 6.3 6.3 5,513 6.2 6.7 5,716 6.3 6
Central  
and Eastern Europe 22,784 7.8 4 13,737 10 6.2 9,047 5.9 2.5
Eastern Africa 11,550 2.7 4.8 7,011 3.3 6.2 4,539 2.1 3.6
Eastern Asia 467,327 28.3 17.7 343,523 40.6 26.8 123,804 15.3 8.7
Melanesia 915 8.7 11.4 557 10.4 14.2 358 6.9 8.9
Micronesia 85 16 15.2 69 25.7 25.6 16 6.1 5.4
Middle Africa 6,010 3.6 6.5 4,137 4.9 9.4 1,873 2.2 3.9
North America 41,851 11.5 6.6 29,900 16.6 10.1 11,951 6.5 3.4
Northern Africa 27,935 11.7 14.1 19,912 16.7 20.8 8,023 6.8 7.8
Northern Europe 10,997 10.5 4.7 7,086 13.7 6.6 3,911 7.4 2.9
Polynesia 67 9.7 9.2 50 14.2 14.4 17 5 4.1
South America 24,248 5.7 4.6 13,565 6.4 5.8 10,683 4.9 3.5
South-Central Asia 44,010 2.2 2.5 29,027 2.9 3.4 14,983 1.6 1.7
South-Eastern Asia 89,010 13.6 13.3 65,407 20 21 23,603 7.2 6.6
Southern Africa 2,710 4.1 4.9 1,692 5.2 7.4 1,018 3 3.2
Southern Europe 25,026 16.4 6.8 17,702 23.7 10.9 7,324 9.4 3.1
Western Africa 16,574 4.3 8.3 10,778 5.6 11.1 5,796 3.1 5.7
Western Asia 9,249 3.4 4 5,787 4.1 5.4 3,462 2.7 2.8
Western Europe 23,659 12.2 5.3 17,300 18.1 8.4 6,359 6.5 2.5
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Figure 3: Age standardized incidence rates of LC by sex in the worldwide 
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Tab. II. The age-standardized mortality rate of liver cancer in different regions of the world in 2018.
Population
All Men Women
Numbers CrudeRate
ASR
(W) Numbers
Crude
Rate
ASR
(W) Numbers
Crude
Rate
ASR
(W)
World 781,631 10.2 8.5 548,375 14.2 12.7 233,256 6.2 4.6
WHO 
regions
WHO Africa 
region (AFRO) 36,239 3.4 5.9 23,315 4.3 8 12,924 2.4 4
WHO Americas 
region (PAHO) 70,775 7 4.8 42,539 8.5 6.3 28,236 5.5 3.4
WHO East 
Mediterranean region 
(EMRO)
38,637 5.6 7.8 26,358 7.4 10.5 12,279 3.7 5
WHO Europe 
region (EURO) 86,407 9.4 4.4 55,850 12.5 6.8 30,557 6.4 2.5
WHO South-East Asia 
region (SEARO) 81,347 4.1 4.3 57,697 5.7 6.2 23,650 2.4 2.4
WHO Western Pacific 
region (WPRO) 468,065 24.2 15.8 342,501 34.7 24.1 125,564 13.3 7.8
Continents
Africa 63,562 4.9 8.3 42,786 6.7 11.9 20,776 3.2 5.2
Asia 566,269 12.5 10.5 410,223 17.6 15.8 156,046 7 5.5
Europe 77,375 10.4 4.4 50,365 14 6.8 27,010 7 2.4
Latin America 
and the Caribbean 36,436 5.6 4.7 19,650 6.1 5.7 16,786 5.1 3.9
North America 34,339 9.4 4.8 22,889 12.7 7.1 11,450 6.2 2.8
Oceania 3,650 8.8 5.8 2,462 11.9 8.3 1,188 5.8 3.4
Human 
Development 
Index (HDI)
China 368,960 25.9 17.1 273,014 37.3 25.6 95,946 13.9 8.6
High HDI 73,651 18 13 45,107 25.5 19.4 28,544 10.3 6.8
India 25,627 1.9 2 17,548 2.5 2.8 8,079 1.2 1.3
Low HDI 32,674 3.2 5.9 20,754 4.1 7.9 11,920 2.3 4.2
Medium HDI 113,443 5 5.7 81,390 7 8.3 32,053 3 3.2
Very high HDI 167,010 12 5.3 110,379 16.1 8.1 56,631 8.1 2.9
Income 
levels
High income 47,477 7.8 2.7 47,477 7.8 2.7 47,477 7.8 2.7
Low income 10,295 2.7 4.5 10,295 2.7 4.5 10,295 2.7 4.5
Low middle income 42,245 2.9 3.1 42,245 2.9 3.1 42,245 2.9 3.1
Upper middle income 129,546 10 6.6 129,546 10 6.6 129,546 10 6.6
World 
regions
Australia  
and New Zealand 2,709 9.2 4.7 1,881 12.8 7 828 5.6 2.5
Caribbean 2,791 6.3 4.7 1,588 7.3 5.8 1,203 5.4 3.7
Central America 10,672 5.9 5.9 5,324 6 6.4 5,348 5.9 5.5
Central 
and Eastern Europe 22,745 7.8 3.9 13,581 9.9 6.1 9,164 5.9 2.4
Eastern Africa 11,251 2.6 4.7 6,799 3.2 6.2 4,452 2 3.5
Eastern Asia 427,932 25.9 16 312,228 36.9 24.2 115,704 14.3 8
Melanesia 819 7.8 10.6 491 9.2 13.1 328 6.3 8.3
Micronesia 68 12.8 12 54 20.1 19.8 14 5.3 4.9
Middle Africa 5,853 3.5 6.5 4,056 4.8 9.5 1,797 2.1 3.9
North America 34,339 9.4 4.8 22,889 12.7 7.1 11,450 6.2 2.8
Northern Africa 27,505 11.6 13.9 19,570 16.4 20.4 7,935 6.7 7.7
Northern Europe 9,997 9.5 3.8 6,088 11.8 5.2 3,909 7.4 2.5
Polynesia 54 7.8 7.4 36 10.2 10.6 18 5.3 4.5
South America 22,973 5.4 4.3 12,738 6 5.5 10,235 4.7 3.4
South-Central Asia 40,812 2.1 2.3 27,060 2.7 3.2 13,752 1.4 1.5
South-Eastern Asia 88,429 13.5 13.2 65,238 19.9 20.9 23,191 7.1 6.5
Southern Africa 2,597 3.9 4.7 1,614 5 7.1 983 2.9 3.1
Southern Europe 21,996 14.4 5.3 14,800 19.8 8.3 7,196 9.2 2.6
Western Africa 16,356 4.3 8.2 10,747 5.6 11.1 5,609 3 5.6
Western Asia 9,096 3.4 4 5,697 4 5.4 3,399 2.6 2.8
Western Europe 22,637 11.7 4.5 15,896 16.6 7 6,741 6.9 2.2
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of LC in the world, the highest proportion occurred 
in Asia and the lowest proportion in Oceania, so that 
72.44% of cases occurred in Asia, 9.89% in Europe, 
4.39% in North America, 4.66% in Latin America and 
Caribbean, 8.13% in Africa and 0.49% in Oceania 
(Tab.  II, Figs. 1-4). In addition, numbers, crude rate 
and ASMR of LC in worldwide countries are visible in 
the Supplementary data (Tab. SII).
The ASIR and ASMR of LC according  
to the WHO classification 
The ASIR of LC was equal to 17.4 (26.4 in men, and 8.5 
in women) in WPRO, 5.1(7.9 in men, and 2.8 in women) 
in EURO, 5.6 (7.8 in men and 3.7 in women) in PAHO, 
4.5 (6.5 in men and 2.6 in women) in SEARO, 7.9 (10.7 
in men and 5 in women) in EMRO, and 6 (8.1 in men 
and 4.1 in women) in AFRO. Of the total incidence of 
this disease, 60.33% occurred in WPRO, 10.93% in 
EURO, 9.54% in PAHO, 10.07% in SEARO, 4.68% in 
EMRO, and 4.46% in AFRO (Tab. I).
The ASMR of LC was equal to 15.8(24.1 in men, and 
7.8 in women) in WPRO, 4.4 (6.8 in men, and 2.5 in 
women) in EURO, 4.8 (6.3 in men and 3.4 in women) in 
PAHO, 4.3 (6.2 in men and 2.4 in women) in SEARO, 
7.8 (10.5 in men and 5 in women) in EMRO, and 5.9 (8 
in men and 4 in women) in AFRO. Of the total mortality 
of this disease, 59.88% occurred in WPRO, 11.05% in 
EURO, 9.05% in PAHO, 10.4% in SEARO, 4.94% in 
EMRO, and 4.68% in AFRO (Tab. II). 
The ASIR and ASMR of LC according  
to the levels of Human Development Index (HDI) 
The ASIR of LC was equal to 6.9 (10.6 in men, and 3.5 
in women) in regions with very high HDI, 13.8 (20.8 in 
men, and 7.2 in women) in regions with high HDI, 5.9 
(8.6 in men and 3.3 in women) in regions with medium 
HDI, 6 (7.9 in men and 4.3 in women) in regions with 
low HDI, 18.3 (27.6 in men and 9 in women) in China, 
and 2.2 (3.1 in men and 1.4 in women) in India. Of 
the total incidence of this disease, 23.19% occurred in 
regions with very high HDI, 9.04% in regions with high 
HDI, 13.74% in regions with medium HDI, 3.97% in 
regions with low HDI, 46.70% in China,and 3.28% in 
India (Tab. I)
The ASMR of LC was equal to 5.3 (8.1 in men, and 2.9 in 
women) in regions with very high HDI, 13 (19.4 in men, 
and 6.8 in women) in regions with high HDI, 5.7 (8.3 in 
men and 3.2 in women) in regions with medium HDI, 
and 5.9 (7.9 in men and 4.2 in women) in regions with 
low HDI. Of the total incidence of this disease, 21.36% 
occurred in regions with very high HDI, 9.42% in 
regions with high HDI, 14.51% in regions with medium 
HDI, and 4.18% in regions with low HDI, 47.20% in 
China,and 3.33% in India (Tab. II).
Predicting the incidence and mortality  
of LC from 2018 to 2040
The number of new cases of LC is predicted to increase 
from 841,080 case in 2018 to 883,925 (+5.1%), 997,895 
(+18.6%), 1,118,358 (+33.0%), 1,241,726 (+47.6%) 
and 1361836 (+61.9%) case in 2020, 2025, 2030, 
2035 and 2040, respectively.In addition, the number 
of mortality from LC increases from 781631 case in 
2018 to 821,727 (+5.1), 930,121 (+19.0%), 1,046,114 
(+33.8%), 1,166,317 (+49.2%) and 1,284,252 (+64.3%) 
case in 2020, 2025, 2030, 2035 and 2040, respectively 
(Tab. III).
Relationship between ASIR and ASMR  
of LC worldwide 
There was a statistically significant correlation between 
ASIR and ASMR of LC worldwide at the level of 0.987 
(P ≥ 0.001). This correlation was equal to 0.994 (P ≥ 0.001) 
in Asia, 0.848 (P ≥ 0.001) in Europe, 0.996 (P ≥ 0.001) in 
Africa, 0.964 (P  ≥ 0.001) in the Latin America and the 
Caribbean and 0.764 (P = 0.010) in Oceania (Fig. 5).
Discussion 
The present study was based on data from GLOBOCAN 
PROJECT that was internationally conducted by WHO 
in 2018. The study aimed to examine the geographical 
distribution of incidence and mortality of LC based 
on geographical, political and economic divisions at 
the international level. It also predicts the number 
of incidence and mortality cases of LC from 2018 to 
2040. 
Cancer is considered as an important health problem 
in developing countries, especially Asian countries, so 
that it is one of the most important causes of death 
in some Asian countries such as South Korea and 
Japan. It seems that if current management plans and 
strategies are not changed, the number of deaths from 
cancer will increase by more than 7000000 per year 
in these areas until 2020  [18, 19]. According to this, 
current study found that most cases of incidence and 
mortality of LC occurred in less developed regions of 
the world in 2018. According to a research by Chang 
et al., hepatocellular carcinoma (HCC) caused by the 
chronic infection with hepatitis B was more common 
in areas with a low and moderate HDI mostly in Asia 
and Africa  [20]. On the other hand, the increased 
incidence of hepatocellular carcinoma in developed 
countries was due to the higher prevalence of alcohol 
consumption and hepatitis C infection [21].
Distribution of cancer in different regions of the world 
varies according to the HDI. Different cancers are 
considered as the most common cancers in regions 
with low, medium, high and very high HDI. Lung, 
colorectal, prostate, and breast cancers are considered 
as the most common cancers in areas with high and 
very high HDI; and they account for more than 50% 
of all new cancer cases in these areas. Meanwhile, in 
areas with low and moderate HDI, the lung, breast, 
colorectal, stomach, liver and cervical cancers are 
also diagnosed as cancers with the highest incidence 
and severity. However, in areas with low HDI, cancers 
associated with infectious agents account for a high 
proportion of cancer incidence and mortality [21-23]. 
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In 2018, the incidence of LC was 5.1 and 6.6 per 
100,000  people in Europe and North America, 
respectively. While the incidence of this disease was 
11.4 and 8.4 in Asia and Africa, respectively, indicating 
the high incidence of disease in less developed regions 
of the world. Top ten countries with the highest 
incidence of LC in 2018 were as follows: Mongolia 
with ASIR = 117, Egypt with ASIR = 49, Viet Nam 
with ASIR = 39, The Gambia with ASIR = 36.5, Lao 
People’s Democratic Republic with ASIR  =  33.4, 
Thailand with ASIR = 32.2, Guinea with ASIR = 27.9, 
Republic of Korea with ASIR  =  27.7, China with 
ASIR = 27.6,and Democratic Republic of Korea with 
ASIR = 25.4 [21]. Among 10 countries with the highest 
standardized LC incidence worldwide, 3 countries 
were located in Africa and 7 countries in Asia. Most 
of these countries with low or moderate HDI were 
located in less developed regions [6, 24-29].
In the present study, there was a significant statistical 
correlation between ASIR and ASMR of LC in the 
world, Europe, Asia, Africa, the Oceania, and the 
United States, in other words, an increase in the 
incidence of LC significantly enhanced its mortality 
rate. Therefore, appropriate and applied measures and 
programs should be adopted in areas with the highest 
incidence of LC, for primary and secondary prevention 
of disease with the aim to reduce the incidence and 
mortality of LC [30, 31]. Accordingly, it is suggested 
conducting case-control and cohort studies in countries 
and regions with the highest incidence of LC with the 
aim to diagnose the most important risk factors of this 
cancer and the risk attributable to each of these factors 
in order to perform appropriate regional planning to 
reduce the incidence of disease. Furthermore, patients 
need to be diagnosed and treated at early stages of 
disease by conducting appropriate screening programs 
in order to reduce the rate of disease mortality in these 
areas in the long term. 
Limitations of the study
The quality of the collected cancer data in the 
GLOBOCAN project is not similar in all countries, 
especially those with medium or low HDI, so that 
the estimates of some countries are based on the 
recorded cases of cancer in limited areas or based on 
estimates from neighboring countries [24]. Please, see 
the Supplementary data (Tabs. SIII, SIV). for more 
information.
Conclusions
LC is one of the most important cancers in the world 
in terms of incidence and mortality. It is important 
to prevent exposure to known risk factors for LC by 
increasing the level of knowledge and attitudes of the 
community. In addition, it is necessary that health 
policy makers have appropriate planning for providing 
suitable diagnostic and medical service to prevent of 
morbidity and mortality of the population with early 
diagnosis and treatment of patients. 
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Tab. III. Predicting the incidence and mortality cases of LC from 2018 to 2040. 
Year  2018 2020 2025 2030 2035 2040 
Ev
en
t Sex Number Number Demographic 
change  
(APC 0%) 
Number Demographic 
change  
(APC 0%) 
Number Demographic 
change  
(APC 0%) 
Number Demographic 
change  
(APC 0%) 
Number Demographic 
change  
(APC 0%) 
In
ci
d
en
ce
 Males  596,574 626,767 30,193 (+5.1%) 706,015 109,441 (+18.3%) 788,519 191,945 (+32.2%) 872,035 275,461 (+46.2%) 952,887 356,313 (+59.7%) 
Females  244,506 257,158 12,652 (+5.2%) 291,880 47,374 (+19.4%) 329,839 85,333 (+34.9%) 369,691 125,185 (+51.2%) 408,949 164,443 (+67.3%) 
Both 
sexes 
841,080 883,925 42,845 (+5.1%) 997,895 156,815 (+18.6%) 1,118,358 277,278 (+33.0%) 1,241,726 400,646 (+47.6%) 1,361,836 520,756 (+61.9%) 
M
o
rt
al
it
y 
Males  548,375 576,354 27,979 (+5.1%) 650,956 102,581 (+18.7%) 729,536 181,161 (+33.0%) 809,877 261,502 (+47.7%) 888,195 339,820 (+62.0%) 
Females  233,256 245,373 12,171 (+5.2%) 279,165 45,909 (+19.7%) 316,578 83,322 (+35.7%) 356,440 123,184 (+52.8%) 396,057 162,801 (+69.8%) 
Both 
sexes 
781,631 821,727 40,096(+5.1%) 930,121 148,490 (+19.0%) 1,046,114 264,483 (+33.8%) 1,166,317 384,686 (+49.2%) 1,284,252 502,621 (+64.3%) 
 
 
Figure 7: correlation of ASIR and ASMR of LC 
 
 
Fig. 5. Correlation of ASIR and ASMR of LC.
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Tab. S1. The age-standardized incidence rate of LC in 185 countries of the world in 2018. 
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Afghanistan 642 [491.6-838.4] 1.8 3.9 391 [280.8-
544.4] 
2.1 4.9 251 [159.9-394.1] 1.4 3 
Albania 435 [374.3-505.5] 14.8 7.8 265 [218.1-
322.0] 
17.9 10 170 [134.3-215.2] 11.7 5.7 
Algeria 563 [455.6-695.7] 1.3 1.4 311 [231.8-
417.3] 
1.5 1.6 252 [185.8-341.8] 1.2 1.3 
Angola 581 [368.5-915.9] 1.9 3.6 382 [225.1-
648.2] 
2.5 5.2 199 [81.3-486.8] 1.3 2.3 
Argentina 2 343 [2028.2-2706.6] 5.2 3.6 1 364 [1134.2-
1640.3] 
6.2 5 979 [776.7-
1234.0] 
4.3 2.5 
Armenia 474 [370.1-607.1] 16.2 9.7 263 [206.2-
335.5] 
19.1 13.5 211 [57.5-775.0] 13.6 6.9 
Australia 2 438 [2235.6-2658.7] 9.8 5.7 1 729 [1572.3-
1901.4] 
14 8.6 709 [574.1-875.6] 5.7 2.9 
Austria 1 121 [970.7-1294.6] 12.8 5.4 750 [629.9-
893.0] 
17.5 8.2 371 [287.6-478.7] 8.3 3 
Azerbaijan 384 [338.4-435.7] 3.9 3.6 192 [161.9-
227.8] 
3.9 4.1 192 [159.1-231.7] 3.9 3.2 
Bahamas 14 [7.2-27.2] 3.5 2.3 10 [4.1-24.4] 5.1 3.9 4 [1.5-10.8] 2 1.1 
Bahrain 30 [19.1-47.2] 1.9 3.4 20 [11.1-36.0] 2 3.9 10 [4.9-20.4] 1.7 2.7 
Bangladesh 3 128 [2395.3-4084.9] 1.9 2.2 2 352 [1689.1-
3275.0] 
2.8 3.3 776 [494.2-
1218.5] 
0.94 1.1 
Barbados 14 [7.2-27.1] 4.9 2.4 7 [2.7-18.1] 5.1 3 7 [2.8-17.6] 4.7 1.9 
Belarus 555 [471.5-653.3] 5.9 3.3 318 [262.1-
385.8] 
7.2 4.9 237 [174.9-321.2] 4.7 2.1 
Belgium 1 006 [929.9-1088.3] 8.7 4.3 638 [585.3-
695.4] 
11.2 5.9 368 [292.9-462.3] 6.3 2.9 
Belize 19 [11.0-32.7] 5 8.4 14 [6.8-28.7] 7.4 12.2 5 [2.2-11.5] 2.6 4.4 
Benin 298 [196.8-451.3] 2.6 5.1 233 [129.9-
417.8] 
4.1 9.8 65 [36.0-117.3] 1.1 2.1 
Bhutan 35 [30.8-39.7] 4.3 5.3 28 [23.9-32.8] 6.5 7.8 7 [5.7-8.6] 1.8 2.3 
Bolivia, 
Plurinational 
State of 
678 [585.7-784.8] 6 6.1 303 [243.2-
377.5] 
5.4 5.6 375 [308.3-456.2] 6.7 6.7 
Bosnia and 
Herzegovina 
552 [454.5-670.4] 15.8 7.4 295 [228.3-
381.2] 
17.1 9.1 257 [190.8-346.2] 14.4 5.9 
Botswana 62 [44.4-86.6] 2.7 3.9 40 [26.3-60.9] 3.5 6.4 22 [12.7-38.1] 1.9 2.3 
Brazil 12 463 [11341.2-
13695.8] 
5.9 4.7 7 317 [6491.1-
8248.0] 
7.1 6.3 5 146 [4415.6-
5997.2] 
4.8 3.4 
Brunei 38 [23.0-62.8] 8.8 9.9 32 [17.7-57.9] 14.3 17 6 [2.4-15.3] 2.8 3.1 
Bulgaria 559 [491.7-635.6] 7.9 3.6 377 [298.3-
476.4] 
11 5.7 182 [155.7-212.7] 5 1.8 
Burkina Faso 1 296 [553.2-3036.0] 6.6 13.8 789 [319.9-
1946.2] 
8 19.2 507 [39.4-6517.7] 5.1 9.7 
Burundi 400 [211.8-755.3] 3.6 6.3 270 [118.6-
614.4] 
4.9 9 130 [47.7-354.1] 2.3 3.9 
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Cabo Verde 44 [29.2-66.4] 8 10.7 24 [13.6-42.3] 8.7 11.3 20 [11.0-36.3] 7.2 9.3 
Cambodia 2 546 [1376.1-4710.4] 15.7 21.8 1 691 [810.9-
3526.2] 
21.3 34.6 855 [275.1-
2656.9] 
10.3 12.7 
Cameroon 955 [617.8-1476.4] 3.9 6.1 724 [436.5-
1200.9] 
5.9 9.3 231 [98.1-543.8] 1.9 3.1 
Canada 3 889 [3592.5-4210.0] 10.5 5.3 2 608 [2364.3-
2876.9] 
14.2 7.6 1 281 [1119.5-
1465.8] 
6.9 3.2 
Central African 
Republic 
149 [94.5-234.9] 3.1 5.1 104 [61.3-176.5] 4.5 7.5 45 [18.4-110.1] 1.9 3.1 
Chad 405 [256.9-638.5] 2.6 5.5 280 [165.0-
475.1] 
3.6 7.8 125 [51.1-305.8] 1.6 3.4 
Chile 1 582 [1230.7-2033.6] 8.7 5.4 871 [618.9-
1225.8] 
9.7 6.9 711 [491.0-
1029.7] 
7.7 4.2 
China 392 868 [386346.0-
399500.0] 
27.6 18.3 292 898 [287242.0-
298665.0] 
40 27.6 99 970 [96758.9-
103288.0] 
14.5 9 
Colombia 2 279 [1874.9-2770.3] 4.6 3.9 1 195 [915.2-
1560.3] 
4.9 4.6 1 084 [814.0-
1443.5] 
4.3 3.3 
Comoros 29 [15.4-54.8] 3.5 5.7 18 [7.9-41.0] 4.3 7.6 11 [4.0-30.0] 2.7 4.1 
Congo, 
Democratic 
Republic of 
3 613 [2291.8-5695.9] 4.3 8 2 431 [1432.6-
4125.1] 
5.8 11.5 1 182 [483.2-
2891.5] 
2.8 5 
Congo, 
Republic of 
207 [157.7-271.7] 3.8 5.9 146 [105.1-
202.7] 
5.4 8.6 61 [37.6-99.1] 2.3 3.4 
Costa Rica 427 [297.4-613.1] 8.6 6.3 248 [142.8-
430.6] 
10 7.9 179 [110.9-289.0] 7.2 4.8 
Croatia 639 [549.6-742.9] 15.3 6.3 410 [343.8-
488.9] 
20.4 9.9 229 [171.2-306.3] 10.6 3.4 
Cuba 837 [730.9-958.4] 7.3 3.8 498 [419.4-
591.3] 
8.7 4.7 339 [271.9-422.6] 5.9 2.9 
Cyprus 75 [55.3-101.8] 6.3 3.4 51 [35.1-74.1] 8.6 5 24 [14.1-40.9] 4 2 
Czechia 1 063 [946.6-1193.7] 10 4.2 679 [592.7-
777.8] 
13 6.1 384 [307.4-479.7] 7.1 2.6 
Côte d'Ivoire 1 121 [932.5-1347.6] 4.5 8.4 703 [562.0-
879.4] 
5.6 9.7 418 [302.5-577.6] 3.4 6.9 
Denmark 611 [537.3-694.8] 10.6 4.9 426 [364.9-
497.4] 
14.9 7.3 185 [146.9-233.0] 6.4 2.6 
Djibouti 19 [10.1-35.9] 2 2.6 11 [4.8-25.0] 2.3 3.1 8 [2.9-21.8] 1.7 2.2 
Dominican 
Republic 
718 [587.6-877.3] 6.6 6.5 400 [304.1-
526.2] 
7.4 7.6 318 [237.0-426.6] 5.8 5.5 
Ecuador 979 [846.0-1132.9] 5.8 5.3 483 [389.7-
598.6] 
5.7 5.7 496 [406.4-605.3] 5.9 4.9 
Egypt 25 399 [23831.9-
27069.1] 
25.6 32.2 18 471 [17185.0-
19853.3] 
36.8 49 6 928 [6050.8-
7932.4] 
14.1 16.7 
El Salvador 514 [417.9-632.1] 8 6.7 208 [156.0-
277.3] 
6.9 6.4 306 [227.1-412.3] 9 6.9 
Equatorial 
Guinea 
44 [27.9-69.4] 3.3 4.7 34 [20.0-57.7] 4.7 6 10 [4.1-24.5] 1.7 3 
Eritrea 92 [48.7-173.7] 1.8 3.3 50 [22.0-113.8] 1.9 3.7 42 [15.4-114.4] 1.6 2.9 
Estonia 103 [82.3-128.9] 7.9 3.2 61 [45.4-82.0] 10 5.1 42 [29.8-59.2] 6.1 2 
Eswatini 37 [25.3-54.0] 2.7 3.9 20 [12.0-33.4] 3 5 17 [9.7-29.8] 2.4 3.2 
Ethiopia 1 608 [1052.3-2457.1] 1.5 2.7 749 [409.9-
1368.7] 
1.4 2.6 859 [473.1-
1559.6] 
1.6 2.7 
Fiji 76 [65.3-88.4] 8.3 8.3 53 [44.2-63.5] 11.5 12.3 23 [17.4-30.4] 5.1 4.9 
Finland 550 [475.8-635.7] 9.9 3.6 347 [283.3-
425.0] 
12.7 5.2 203 [165.1-249.7] 7.2 2.3 
France 10 624 [10156.6-
11112.9] 
16.3 7.8 8 382 [7967.5-
8818.1] 
26.1 13.3 2 242 [2033.8-
2471.5] 
6.8 2.7 
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France, 
Guadeloupe 
34 [21.8-53.1] 7.6 3.7 22 [12.7-38.1] 10.6 6.2 12 [5.6-25.7] 5 1.7 
France, La 
Réunion 
85 [65.0-111.2] 9.6 6 58 [41.8-80.4] 13.6 9.1 27 [16.8-43.3] 5.9 3.3 
France, 
Martinique 
39 [26.8-56.8] 10.1 4.1 25 [15.6-40.0] 14.3 5.9 14 [7.5-26.3] 6.7 2.7 
France, New 
Caledonia 
38 [24.5-58.9] 13.6 10.4 25 [14.8-42.3] 17.7 14.3 13 [5.9-28.5] 9.4 6.9 
French Guiana 21 [11.0-40.1] 7.2 8.5 18 [8.0-40.6] 12.4 15.5 3 [1.0-8.7] 2.1 2.3 
French 
Polynesia 
34 [22.3-51.9] 11.9 9.5 23 [11.7-45.3] 15.8 13.4 11 [6.4-19.0] 7.8 5.6 
Gabon 55 [36.9-81.9] 2.7 3.3 35 [21.5-56.9] 3.3 3.9 20 [10.0-40.1] 2 2.6 
Gaza Strip and 
West Bank 
47 [24.1-91.8] 0.93 1.8 31 [14.5-66.4] 1.2 2.4 16 [3.9-65.3] 0.64 1.3 
Georgia 380 [322.7-447.5] 9.7 5.4 235 [198.7-
278.0] 
12.6 8.3 145 [81.0-259.4] 7.1 3.1 
Germany 8 883 [8277.0-9533.3] 10.8 4.2 6 191 [5716.5-
6704.9] 
15.3 6.4 2 692 [2311.4-
3135.2] 
6.4 2.3 
Ghana 2 753 [2402.2-3155.0] 9.3 15.4 2 016 [1717.8-
2365.9] 
13.7 24.4 737 [568.3-955.7] 5 7.6 
Greece 1 642 [1486.9-1813.2] 14.7 5.7 1 121 [986.4-
1274.0] 
20.4 8.6 521 [445.3-609.6] 9.2 3.3 
Guam 31 [25.3-37.9] 18.7 14.8 25 [20.0-31.2] 29.8 24.5 6 [3.7-9.8] 7.3 5.3 
Guatemala 1 787 [1592.4-2005.4] 10.4 14.9 854 [723.0-
1008.8] 
10.1 15.8 933 [795.3-
1094.6] 
10.7 14.1 
Guinea 1 582 [1242.4-2014.4] 12.1 21.8 969 [717.7-
1308.3] 
14.8 27.9 613 [408.0-921.0] 9.4 16.3 
Guinea-Bissau 126 [53.8-295.2] 6.6 11.9 84 [34.1-207.2] 8.9 17.3 42 [3.3-539.9] 4.3 7.3 
Guyana 20 [11.9-33.7] 2.6 2.7 10 [4.9-20.5] 2.5 2.7 10 [4.7-21.5] 2.6 2.7 
Haiti 664 [543.7-810.9] 6 8.1 354 [288.2-
434.8] 
6.4 9.5 310 [132.7-724.1] 5.5 6.8 
Honduras 403 [300.0-541.4] 4.3 5.7 302 [206.1-
442.5] 
6.4 9.2 101 [63.4-160.8] 2.1 2.7 
Hungary 1 087 [959.0-1232.1] 11.2 5.4 770 [665.5-
890.9] 
16.7 9.2 317 [248.3-404.8] 6.2 2.4 
Iceland 15 [9.0-25.0] 4.4 2.5 12 [6.2-23.4] 7.1 4.1 3 [1.4-6.6] 1.8 0.95 
India 27 670 [26091.1-
29344.5] 
2 2.2 18 807 [17531.4-
20175.5] 
2.7 3.1 8 863 [7961.8-
9866.2] 
1.4 1.4 
Indonesia 18 468 [16124.1-
21152.6] 
6.9 7.6 14 238 [12130.6-
16711.6] 
10.6 12.4 4 230 [3276.2-
5461.5] 
3.2 3.4 
Iran, Islamic 
Republic of 
3 492 [3303.2-3691.6] 4.3 4.7 1 999 [1860.1-
2148.3] 
4.8 5.3 1 493 [1368.0-
1629.4] 
3.7 4.1 
Iraq 539 [478.6-607.0] 1.4 2.7 278 [236.4-
326.9] 
1.4 3.1 261 [219.2-310.8] 1.3 2.4 
Ireland 363 [301.4-437.2] 7.6 4.3 275 [207.5-
364.5] 
11.5 6.8 88 [68.6-112.8] 3.6 2 
Israel 336 [281.8-400.6] 4 2.6 200 [159.9-
250.2] 
4.8 3.5 136 [102.4-180.6] 3.2 1.7 
Italy 12 325 [11947.7-
12714.2] 
20.8 7.9 8 742 [8418.2-
9078.3] 
30.2 12.8 3 583 [3391.8-
3784.9] 
11.8 3.5 
Jamaica 106 [80.2-140.1] 3.7 2.9 55 [37.8-80.1] 3.8 3 51 [33.6-77.3] 3.5 2.8 
Japan 35 535 [34730.5-
36358.1] 
27.9 7.6 23 448 [22796.6-
24118.0] 
37.8 12.3 12 087 [11621.1-
12571.5] 
18.6 3.5 
Jordan 188 [148.6-237.8] 1.9 3.1 101 [74.4-137.2] 2 3.4 87 [60.3-125.6] 1.8 2.7 
Kazakhstan 1 122 [1045.7-1203.9] 6.1 5.6 655 [597.0-
718.6] 
7.3 8.2 467 [419.0-520.5] 4.9 3.9 
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Kenya 1 346 [1050.6-1724.5] 2.6 5.3 761 [556.8-
1040.0] 
3 6.2 585 [389.4-878.9] 2.3 4.5 
Korea, 
Democratic 
Republic of 
5 718 [5354.5-6106.2] 22.3 16.5 3 831 [3524.8-
4163.8] 
30.6 25.4 1 887 [1695.9-
2099.6] 
14.4 9 
Korea, 
Republic of 
16 510 [15880.0-
17165.0] 
32.3 17.3 12 180 [11648.7-
12735.6] 
47.6 27.7 4 330 [3998.8-
4688.6] 
16.9 8.2 
Kuwait 121 [94.5-155.0] 2.9 5.2 88 [65.4-118.3] 3.7 6.2 33 [21.0-51.8] 1.8 3.7 
Kyrgyzstan 456 [371.5-559.7] 7.4 9.5 267 [200.2-
356.1] 
8.8 13 189 [141.2-252.9] 6.1 6.9 
Lao People's 
Democratic 
Republic 
1 035 [559.4-1914.9] 14.9 22.4 712 [341.4-
1484.7] 
20.5 33.4 323 [103.9-
1003.7] 
9.3 13.1 
Latvia 152 [112.4-205.5] 7.9 3.1 63 [43.0-92.3] 7.1 3.8 89 [54.4-145.7] 8.5 2.6 
Lebanon 227 [185.8-277.3] 3.7 3.2 133 [102.4-
172.8] 
4.4 3.6 94 [68.9-128.2] 3.1 2.6 
Lesotho 68 [39.0-118.4] 3 4.4 41 [20.3-82.7] 3.7 6.6 27 [10.9-66.8] 2.3 3 
Liberia 412 [175.9-965.1] 8.5 15.2 247 [100.1-
609.3] 
10.1 18.9 165 [12.8-2121.1] 6.9 11.7 
Libya 191 [125.0-291.8] 3 4.1 98 [55.9-171.9] 3 4.4 93 [48.8-177.3] 2.9 3.8 
Lithuania 246 [206.6-292.9] 8.6 3.8 160 [121.7-
210.3] 
12.1 6.5 86 [68.4-108.1] 5.5 1.9 
Luxembourg 70 [48.8-100.5] 11.9 6.5 48 [30.8-74.8] 16.2 9.1 22 [11.8-41.0] 7.5 4.2 
Madagascar 898 [475.6-1695.7] 3.4 5.8 584 [256.6-
1329.0] 
4.5 8.3 314 [115.3-855.3] 2.4 3.6 
Malawi 291 [162.5-521.2] 1.5 2.1 167 [78.6-354.9] 1.8 2.4 124 [49.5-310.7] 1.3 1.8 
Malaysia 1 944 [1785.5-2116.6] 6.1 6.3 1 460 [1322.7-
1611.5] 
8.8 9.5 484 [409.4-572.1] 3.1 3.1 
Maldives 27 [20.7-35.3] 6.1 8.3 22 [15.8-30.6] 8.7 12.3 5 [3.2-7.9] 2.6 3.7 
Mali 598 [473.6-755.0] 3.1 6.3 438 [335.3-
572.2] 
4.6 10.2 160 [99.3-257.8] 1.7 2.9 
Malta 22 [13.9-34.8] 5.1 2.2 15 [8.4-26.9] 6.9 3.5 7 [3.3-14.6] 3.3 0.94 
Mauritania 320 [136.6-749.6] 7 11.3 221 [89.6-545.1] 9.7 16.8 99 [7.7-1272.7] 4.4 6.6 
Mauritius 63 [46.6-85.1] 5 3.2 36 [24.3-53.3] 5.7 4 27 [16.9-43.2] 4.2 2.6 
Mexico 7 265 [6896.2-7653.6] 5.6 5.4 3 450 [3220.8-
3695.5] 
5.3 5.5 3 815 [3522.2-
4132.1] 
5.8 5.4 
Mongolia 2 241 [2129.2-2358.6] 71.8 93.7 1 299 [1214.3-
1389.6] 
84.2 117 942 [870.8-
1019.0] 
59.7 74.1 
Montenegro 52 [34.8-77.6] 8.3 3.9 33 [19.8-55.0] 10.6 5.7 19 [10.0-36.2] 6 2.5 
Morocco 428 [294.4-622.3] 1.2 1.1 243 [147.9-
399.3] 
1.4 1.4 185 [104.7-326.9] 1 0.95 
Mozambique 1 200 [953.3-1510.5] 3.9 6.6 675 [499.9-
911.4] 
4.5 8.8 525 [366.9-751.1] 3.4 5 
Myanmar 5 304 [2866.9-9812.9] 9.8 10.1 3 532 [1693.8-
7365.1] 
13.4 14.6 1 772 [570.2-
5506.5] 
6.4 6.2 
Namibia 48 [30.2-76.2] 1.9 2.8 31 [17.3-55.7] 2.5 4.2 17 [8.0-36.2] 1.3 1.8 
Nepal 282 [195.5-406.8] 0.95 1.1 175 [110.2-
277.8] 
1.2 1.5 107 [58.7-195.1] 0.7 0.82 
New Zealand 483 [398.0-586.2] 10.2 5.8 386 [267.1-
557.8] 
16.5 10 97 [76.9-122.4] 4 2 
Nicaragua 565 [470.3-678.7] 9 10.5 322 [256.8-
403.7] 
10.4 13.6 243 [177.6-332.4] 7.6 8 
Niger 775 [505.4-1188.4] 3.5 7.3 587 [355.8-
968.3] 
5.2 11.5 188 [82.7-427.6] 1.7 3.3 
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Nigeria 5 129 [3969.6-6626.9] 2.6 5.1 3 087 [2271.3-
4195.7] 
3.1 5.9 2 042 [1281.7-
3253.2] 
2.1 4.3 
Norway 334 [280.6-397.5] 6.2 3.4 248 [191.3-
321.4] 
9.2 5.3 86 [68.0-108.7] 3.2 1.5 
Oman 117 [80.4-170.3] 2.4 4.4 90 [56.8-142.7] 2.8 5.8 27 [14.1-51.6] 1.7 2.7 
Pakistan 4 381 [3740.5-5131.2] 2.2 3.1 2 729 [2244.4-
3318.3] 
2.6 3.8 1 652 [1262.9-
2160.9] 
1.7 2.3 
Panama 249 [195.8-316.7] 6 4.8 115 [82.3-160.7] 5.5 4.9 134 [94.8-189.4] 6.5 4.7 
Papua New 
Guinea 
732 [634.1-845.0] 8.7 11.9 425 [360.6-
500.9] 
9.9 14 307 [228.7-412.1] 7.4 10 
Paraguay 181 [129.6-252.8] 2.6 2.8 115 [73.9-179.0] 3.3 3.7 66 [39.6-109.9] 1.9 2 
Peru 2 317 [2021.7-2655.4] 7.1 6.6 1 104 [914.3-
1333.1] 
6.8 6.8 1 213 [995.8-
1477.6] 
7.4 6.4 
Philippines 9 628 [9132.7-10150.2] 9 11.5 6 848 [6430.4-
7292.7] 
12.8 17.8 2 780 [2522.5-
3063.7] 
5.3 6.2 
Poland 2 569 [2346.3-2812.9] 6.7 3.2 1 541 [1364.3-
1740.6] 
8.4 4.7 1 028 [897.4-
1177.6] 
5.2 2.1 
Portugal 1 386 [1234.7-1555.8] 13.5 5.4 983 [859.6-
1124.1] 
20.2 9.2 403 [321.0-506.0] 7.4 2.2 
Puerto Rico 351 [310.6-396.7] 9.6 5.2 251 [219.6-
286.9] 
14.3 8.9 100 [68.7-145.5] 5.3 2.3 
Qatar 42 [31.5-56.1] 1.6 4.1 37 [26.5-51.7] 1.8 5.7 5 [2.8-8.9] 0.74 1.8 
Republic of 
Moldova 
852 [708.4-1024.7] 21.1 13.8 539 [430.5-
674.8] 
27.8 20.9 313 [226.4-432.7] 14.9 8.4 
Romania 3 451 [3253.3-3660.7] 17.6 8.4 2 229 [2065.1-
2405.9] 
23.5 12.7 1 222 [1113.6-
1340.9] 
12.1 4.9 
Russian 
Federation 
10 349 [10051.8-
10655.0] 
7.2 3.9 5 946 [5700.9-
6201.6] 
8.9 6 4 403 [4228.8-
4584.4] 
5.7 2.5 
Rwanda 737 [498.4-1089.8] 5.9 10.1 483 [296.1-
788.0] 
7.9 14.7 254 [132.5-486.9] 4 6.6 
Saint Lucia 4 [2.4-6.6] 2.2 1.5 3 [1.7-5.4] 3.4 2.2 1 [0.40-2.7] 1.1 0.83 
Samoa 16 [10.0-25.7] 8.1 9.8 14 [6.6-29.9] 13.7 17.3 2 [1.1-3.7] 2.1 2.5 
Sao Tome and 
Principe 
8 [3.4-18.7] 3.8 8.3 7 [2.8-17.3] 6.7 14.8 1 [0.10-12.9] 0.95 2.6 
Saudi Arabia 905 [764.2-1071.7] 2.7 4.5 676 [554.5-
824.2] 
3.5 6.2 229 [165.6-316.6] 1.6 2.5 
Senegal 1 075 [458.9-2518.3] 6.6 12.6 673 [272.8-
1660.1] 
8.4 18 402 [31.3-5167.9] 4.9 8.4 
Serbia 772 [671.3-887.8] 8.8 4.4 460 [383.8-
551.3] 
10.7 5.9 312 [250.4-388.8] 7 3.2 
Sierra Leone 406 [370.8-444.6] 5.3 10 248 [222.7-
276.2] 
6.5 12.6 158 [133.5-187.0] 4.1 7.5 
Singapore 1 378 [1234.4-1538.3] 23.8 12.3 1 000 [882.0-
1133.7] 
34.9 19.5 378 [277.0-515.8] 12.9 5.9 
Slovakia 512 [461.2-568.4] 9.4 5 335 [294.2-
381.5] 
12.6 7.7 177 [148.5-210.9] 6.3 2.9 
Slovenia 292 [243.0-350.8] 14 5.8 216 [166.6-
280.1] 
20.9 9.7 76 [58.7-98.4] 7.3 2.3 
Solomon 
Islands 
41 [34.5-48.7] 6.6 10.3 32 [26.1-39.3] 10.1 15.5 9 [6.6-12.4] 2.9 5.1 
Somalia 253 [134.0-477.7] 1.7 3.4 132 [58.0-300.4] 1.7 3.6 121 [44.4-329.6] 1.6 3.2 
South Africa 2 495 [2258.3-2756.5] 4.3 5 1 560 [1372.5-
1773.2] 
5.5 7.6 935 [797.8-
1095.8] 
3.2 3.3 
South Sudan 397 [210.2-749.6] 3.1 5.1 249 [109.4-
566.7] 
3.8 6.5 148 [54.3-403.1] 2.3 3.8 
Spain 6 630 [6218.4-7068.8] 14.3 6.5 4 976 [4616.0-
5364.1] 
21.9 10.9 1 654 [1462.6-
1870.4] 
7 2.4 
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Sri Lanka 767 [644.7-912.5] 3.7 2.7 472 [387.5-
574.9] 
4.7 3.6 295 [204.3-426.0] 2.7 1.9 
Sudan 942 [640.2-1386.1] 2.3 3.8 581 [360.6-
936.1] 
2.8 4.8 361 [186.9-697.3] 1.7 2.8 
Suriname 34 [22.7-51.0] 6 5.6 25 [14.9-42.0] 8.8 9 9 [4.7-17.2] 3.2 2.6 
Sweden 974 [880.1-1077.9] 9.8 4.5 641 [567.0-
724.7] 
12.8 6.5 333 [278.2-398.6] 6.7 2.6 
Switzerland 946 [875.7-1021.9] 11.1 4.8 664 [607.6-
725.7] 
15.7 7.3 282 [241.3-329.6] 6.5 2.7 
Syrian Arab 
Republic 
380 [194.6-742.2] 2.1 3 200 [93.4-428.1] 2.2 3.4 180 [44.1-734.9] 2 2.6 
Tajikistan 272 [219.9-336.5] 3 4.7 163 [124.4-
213.6] 
3.6 6 109 [77.2-153.9] 2.4 3.7 
Tanzania, 
United 
Republic of 
1 537 [1081.3-2184.8] 2.6 4.9 1 162 [757.1-
1783.4] 
4 8.1 375 [202.6-694.2] 1.3 2.2 
Thailand 23 296 [22644.5-
23966.2] 
33.7 21 16 299 [15759.3-
16857.2] 
48.3 32.2 6 997 [6638.4-
7375.0] 
19.7 11.4 
The former 
Yugoslav 
Republic of 
Macedonia 
185 [122.7-278.9] 8.9 5 121 [71.5-204.9] 11.6 7.1 64 [33.2-123.2] 6.1 3.1 
The 
Netherlands 
1 001 [891.7-1123.7] 5.9 2.5 620 [527.1-
729.2] 
7.3 3.4 381 [323.1-449.3] 4.4 1.8 
The Republic 
of the Gambia 
319 [273.7-371.9] 14.7 23.9 245 [205.5-
292.1] 
22.9 36.5 74 [54.1-101.3] 6.8 12 
Timor-Leste 38 [20.5-70.3] 2.9 5.3 27 [12.9-56.3] 4 7.3 11 [3.5-34.2] 1.7 3.2 
Togo 312 [280.2-347.5] 3.9 6.9 207 [182.0-
235.4] 
5.2 9.7 105 [86.2-127.9] 2.6 4.4 
Trinidad and 
Tobago 
66 [45.7-95.4] 4.8 3.3 36 [21.7-59.7] 5.3 3.9 30 [17.5-51.3] 4.3 2.8 
Tunisia 355 [254.1-496.0] 3 2.6 163 [105.7-
251.5] 
2.8 2.5 192 [113.5-324.7] 3.3 2.7 
Turkey 4 362 [3969.3-4793.5] 5.3 4.5 2 779 [2484.7-
3108.1] 
6.9 6.6 1 583 [1328.5-
1886.2] 
3.8 2.8 
Turkmenistan 281 [237.9-331.8] 4.8 6 175 [141.4-
216.5] 
6.1 8.4 106 [81.2-138.3] 3.6 4.1 
Uganda 1 811 [1416.2-2315.9] 4.1 7.6 1 169 [847.3-
1612.8] 
5.3 10.1 642 [438.5-939.9] 2.9 5.4 
Ukraine 1 787 [1660.4-1923.2] 4.1 2.2 1 003 [910.7-
1104.6] 
4.9 3.2 784 [700.0-878.1] 3.3 1.6 
United Arab 
Emirates 
97 [76.6-122.9] 1 4.2 62 [46.2-83.2] 0.9 4.3 35 [23.5-52.0] 1.3 4.3 
United 
Kingdom 
7 618 [7346.6-7899.4] 11.4 5.1 4 832 [4625.2-
5048.1] 
14.7 7 2 786 [2611.0-
2972.7] 
8.3 3.3 
United States of 
America 
37 948 [37032.2-
38886.5] 
11.6 6.8 27 282 [26426.9-
28164.8] 
16.9 10.4 10 666 [10267.4-
11080.1] 
6.5 3.4 
Uruguay 158 [123.5-202.2] 4.6 2.6 114 [78.7-165.1] 6.8 4.4 44 [31.5-61.4] 2.5 1.3 
Uzbekistan 1 455 [1332.6-1588.7] 4.5 5.6 792 [705.3-
889.4] 
4.9 6.8 663 [579.4-758.7] 4.1 4.6 
Vanuatu 28 [17.1-45.8] 9.9 13.1 22 [12.8-37.9] 15.4 20.2 6 [1.9-18.8] 4.3 6.2 
Venezuela, 
Bolivarian 
Republic of 
1 193 [1044.6-1362.5] 3.7 3.6 646 [523.7-
796.8] 
4 4.3 547 [460.8-649.4] 3.4 3 
Viet Nam 25 335 [23627.6-
27165.8] 
26.3 23.2 19 568 [18064.2-
21197.0] 
41 39 5 767 [4999.5-
6652.4] 
11.8 9.5 
Yemen 620 [511.0-752.3] 2.1 4.4 402 [315.1-
512.9] 
2.8 6.3 218 [158.6-299.7] 1.5 2.7 
Zambia 194 [114.5-328.7] 1.1 2.2 108 [54.7-213.1] 1.2 2.8 86 [37.3-198.4] 0.97 1.8 
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Zimbabwe 577 [468.9-710.0] 3.4 6.9 321 [246.0-
418.9] 
3.9 8.7 256 [183.9-356.4] 3 5.6 
World 841 080 [817635.0-
865198.0] 
11 9.3 596 574 [576976.0-
616838.0] 
15.5 13.9 244 506 [231861.0-
257840.0] 
6.5 4.9 
 
 
Tab. SII. The age-standardized mortality rate of LC in 185 countries of the world in 2018. 
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Afghanistan 621 [487.6-790.9] 1.7 3.8 374 [277.1-
504.9] 
2 4.7 247 [164.1-371.8] 1.4 2.9 
Albania 430 [370.0-499.7] 14.7 7.6 259 [213.1-
314.8] 
17.5 9.6 171 [135.1-216.5] 11.8 5.7 
Algeria 544 [424.3-697.5] 1.3 1.4 302 [213.8-
426.6] 
1.4 1.6 242 [169.2-346.1] 1.2 1.2 
Angola 547 [355.7-841.3] 1.8 3.5 350 [212.3-
577.1] 
2.3 4.8 197 [84.5-459.0] 1.3 2.3 
Argentina 2 113 [1963.0-2274.4] 4.7 3.2 1 206 [1095.1-
1328.2] 
5.5 4.4 907 [809.3-
1016.4] 
4 2.3 
Armenia 455 [370.9-558.2] 15.5 9.4 262 [214.2-
320.4] 
19 13.5 193 [65.9-565.6] 12.4 6.3 
Australia 2 356 [2200.3-2522.8] 9.5 4.8 1 617 [1485.9-
1759.6] 
13.1 7.2 739 [657.8-830.2] 5.9 2.6 
Austria 947 [852.6-1051.8] 10.8 4.3 696 [618.1-
783.7] 
16.2 7.2 251 [200.5-314.2] 5.6 1.8 
Azerbaijan 374 [320.8-436.0] 3.8 3.5 184 [149.5-
226.4] 
3.7 3.9 190 [151.2-238.7] 3.8 3.2 
Bahamas 14 [7.9-24.8] 3.5 2.3 10 [4.6-21.5] 5.1 3.9 4 [1.7-9.4] 2 1.1 
Bahrain 28 [16.2-48.3] 1.8 3.3 18 [9.0-36.1] 1.8 3.7 10 [4.2-23.9] 1.7 2.7 
Bangladesh 2 841 [2230.6-3618.4] 1.7 2 2 117 [1568.3-
2857.7] 
2.5 3.1 724 [481.0-
1089.7] 
0.88 0.99 
Barbados 14 [7.8-25.0] 4.9 2.4 7 [3.0-16.1] 5.1 3 7 [3.1-15.7] 4.7 1.9 
Belarus 374 [311.0-449.8] 4 2.2 249 [195.9-
316.5] 
5.7 3.8 125 [93.7-166.8] 2.5 1.1 
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Belgium 1 004 [926.6-1087.9] 8.7 3.6 630 [576.2-
688.9] 
11.1 5.1 374 [305.7-457.6] 6.4 2.1 
Belize 19 [11.9-30.4] 5 8.4 14 [7.5-26.0] 7.4 12.2 5 [2.4-10.2] 2.6 4.4 
Benin 309 [193.6-493.1] 2.7 5.3 237 [122.8-
457.4] 
4.1 9.9 72 [37.0-139.9] 1.3 2.3 
Bhutan 33 [28.8-37.8] 4 5.1 27 [22.8-32.0] 6.2 7.6 6 [4.8-7.5] 1.6 2 
Bolivia, 
Plurinational 
State of 
667 [580.7-766.1] 5.9 6 299 [242.8-
368.2] 
5.3 5.5 368 [305.7-443.1] 6.6 6.6 
Bosnia and 
Herzegovina 
524 [473.3-580.2] 15 6.4 276 [240.0-
317.4] 
16 7.9 248 [213.8-287.7] 13.9 5.2 
Botswana 60 [40.7-88.4] 2.6 3.8 39 [23.9-63.6] 3.4 6.3 21 [11.1-39.7] 1.8 2.2 
Brazil 11 797 [11462.0-
12141.8] 
5.6 4.4 6 906 [6660.3-
7160.7] 
6.7 5.9 4 891 [4664.0-
5129.1] 
4.6 3.2 
Brunei 31 [20.2-47.6] 7.1 8.3 26 [14.1-48.0] 11.6 14 5 [2.7-9.1] 2.4 2.8 
Bulgaria 585 [515.5-663.9] 8.3 3.6 378 [328.0-
435.6] 
11.1 5.4 207 [156.5-273.8] 5.7 2 
Burkina Faso 1 269 [682.7-2358.8] 6.4 13.5 771 [399.5-
1488.1] 
7.8 18.7 498 [77.5-3198.4] 5 9.5 
Burundi 409 [213.6-783.0] 3.6 6.6 288 [124.3-
667.2] 
5.2 9.7 121 [43.5-336.8] 2.1 3.8 
Cabo Verde 47 [32.7-67.5] 8.5 11.2 26 [15.8-42.8] 9.4 11.8 21 [12.4-35.5] 7.6 9.7 
Cambodia 2 546 [1408.7-4601.4] 15.7 21.9 1 695 [839.2-
3423.4] 
21.4 34.7 851 [284.2-
2548.5] 
10.2 12.7 
Cameroon 895 [581.9-1376.5] 3.6 6 683 [414.2-
1126.1] 
5.5 9.2 212 [91.0-494.0] 1.7 2.9 
Canada 3 845 [3578.4-4131.4] 10.4 4.5 2 318 [2129.3-
2523.5] 
12.6 6 1 527 [1334.5-
1747.3] 
8.2 3.2 
Central 
African 
Republic 
133 [86.5-204.5] 2.8 4.8 91 [55.2-150.0] 3.9 6.9 42 [18.0-97.9] 1.7 2.9 
Chad 372 [241.9-572.1] 2.4 5.3 254 [154.1-
418.8] 
3.3 7.5 118 [50.6-275.0] 1.5 3.3 
Chile 1 448 [1336.6-1568.7] 8 4.9 781 [701.3-
869.8] 
8.7 6.1 667 [591.7-751.9] 7.3 3.9 
China 368 960 [363309.0-
374699.0] 
25.9 17.1 273 014 [268132.0-
277985.0] 
37.3 25.6 95 946 [93128.5-
98848.7] 
13.9 8.6 
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Colombia 2 216 [2048.6-2397.1] 4.5 3.8 1 156 [995.2-
1342.7] 
4.8 4.5 1 060 [966.6-
1162.5] 
4.2 3.2 
Comoros 28 [14.6-53.6] 3.4 5.8 18 [7.8-41.7] 4.3 7.8 10 [3.6-27.8] 2.4 3.9 
Congo, 
Democratic 
Republic of 
3 624 [2356.4-5573.6] 4.3 8.1 2 479 [1503.5-
4087.3] 
5.9 11.9 1 145 [491.4-
2668.1] 
2.7 4.9 
Congo, 
Republic of 
186 [136.9-252.6] 3.4 5.4 131 [90.5-189.6] 4.8 8 55 [31.9-95.0] 2 3.2 
Costa Rica 395 [331.3-470.9] 8 5.6 238 [188.7-
300.2] 
9.6 7.2 157 [120.0-205.4] 6.3 4.1 
Croatia 547 [483.6-618.7] 13.1 5.2 364 [314.8-
420.8] 
18.1 8.4 183 [145.0-231.0] 8.5 2.6 
Cuba 773 [691.1-864.6] 6.7 3.3 448 [388.7-
516.3] 
7.8 4.1 325 [270.9-390.0] 5.7 2.6 
Cyprus 101 [77.6-131.5] 8.5 4.6 64 [46.1-88.9] 10.8 6.3 37 [23.8-57.5] 6.2 3 
Czechia 874 [784.7-973.4] 8.2 3.2 565 [491.2-
649.9] 
10.8 4.8 309 [261.0-365.8] 5.7 2 
Côte d'Ivoire 1 130 [914.3-1396.5] 4.5 8.4 712 [550.3-
921.2] 
5.6 9.8 418 [288.2-606.3] 3.4 6.9 
Denmark 580 [501.2-671.2] 10.1 4.2 370 [304.9-
449.1] 
12.9 5.9 210 [168.1-262.3] 7.3 2.6 
Djibouti 17 [8.9-32.5] 1.8 2.4 10 [4.3-23.2] 2.1 2.9 7 [2.5-19.5] 1.4 2 
Dominican 
Republic 
650 [548.9-769.8] 6 5.8 353 [280.1-
444.9] 
6.5 6.7 297 [231.8-380.6] 5.4 5 
Ecuador 953 [860.4-1055.6] 5.7 5.1 471 [405.2-
547.5] 
5.6 5.5 482 [419.3-554.1] 5.7 4.7 
Egypt 25 084 [23515.3-
26757.3] 
25.2 31.8 18 209 [16924.1-
19591.5] 
36.2 48.4 6 875 [5993.1-
7886.7] 
14 16.6 
El Salvador 500 [416.7-599.9] 7.8 6.5 202 [156.8-
260.2] 
6.7 6.2 298 [229.2-387.4] 8.8 6.8 
Equatorial 
Guinea 
42 [27.3-64.6] 3.2 4.9 33 [20.0-54.4] 4.5 6.5 9 [3.9-21.0] 1.5 2.9 
Eritrea 90 [47.0-172.3] 1.7 3.2 49 [21.2-113.5] 1.9 3.7 41 [14.7-114.1] 1.6 2.8 
Estonia 95 [76.6-117.9] 7.3 2.9 57 [43.0-75.6] 9.3 4.8 38 [27.2-53.1] 5.5 1.6 
Eswatini 35 [22.4-54.6] 2.5 3.9 19 [10.4-34.7] 2.8 5 16 [8.3-30.9] 2.2 3.2 
Ethiopia 1 656 [1032.5-2655.9] 1.5 2.7 759 [387.7-
1485.8] 
1.4 2.7 897 [461.5-
1743.3] 
1.7 2.8 
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Fiji 75 [56.2-100.2] 8.2 8.2 53 [37.6-74.7] 11.5 12.2 22 [12.8-37.7] 4.9 4.6 
Finland 579 [507.0-661.2] 10.4 3.6 377 [312.9-
454.2] 
13.8 5.5 202 [167.2-244.1] 7.2 2.1 
France 10 063 [9742.7-10393.8] 15.4 6.3 7 376 [7117.9-
7643.5] 
23 10.4 2 687 [2487.4-
2902.6] 
8.1 2.6 
France, 
Guadeloupe 
30 [19.9-45.2] 6.7 2.6 20 [12.0-33.4] 9.6 4.2 10 [5.0-19.9] 4.1 1.3 
France, La 
Réunion 
89 [69.1-114.6] 10.1 6.1 60 [44.0-81.9] 14 9.3 29 [18.8-44.7] 6.4 3.3 
France, 
Martinique 
38 [26.1-55.4] 9.9 3.8 22 [13.4-36.2] 12.6 5.1 16 [9.0-28.4] 7.6 2.7 
France, New 
Caledonia 
26 [16.8-40.3] 9.3 6.8 19 [11.3-32.0] 13.5 10.6 7 [3.1-15.6] 5 3.4 
French Guiana 12 [7.5-19.2] 4.1 4.9 11 [5.2-23.3] 7.6 9.5 1 [0.50-1.8] 0.69 0.7 
French 
Polynesia 
34 [22.3-51.8] 11.9 9.5 23 [12.2-43.3] 15.8 13.4 11 [6.2-19.4] 7.8 5.6 
Gabon 52 [35.4-76.4] 2.5 3.3 33 [20.6-52.8] 3.1 3.9 19 [9.7-37.2] 1.9 2.6 
Gaza Strip and 
West Bank 
45 [24.8-81.7] 0.89 1.8 30 [15.3-58.9] 1.2 2.4 15 [4.3-52.9] 0.6 1.2 
Georgia 370 [319.4-428.6] 9.5 5.2 227 [195.2-
264.0] 
12.2 8 143 [84.8-241.3] 7 3 
Germany 8 643 [8358.0-8937.7] 10.5 3.8 5 936 [5685.9-
6197.1] 
14.6 5.7 2 707 [2566.0-
2855.7] 
6.5 2.1 
Ghana 2 737 [2351.4-3185.8] 9.3 15.4 2 000 [1673.3-
2390.5] 
13.6 24.3 737 [551.7-984.5] 5 7.6 
Greece 1 478 [1355.7-1611.4] 13.3 4.5 984 [880.2-
1100.0] 
17.9 6.7 494 [430.8-566.4] 8.7 2.7 
Guam 25 [19.8-31.5] 15.1 11.9 20 [15.4-26.0] 23.8 19.2 5 [3.1-8.1] 6.1 4.9 
Guatemala 1 741 [1578.0-1920.8] 10.1 14.5 832 [721.8-
959.0] 
9.8 15.4 909 [793.3-
1041.6] 
10.4 13.8 
Guinea 1 413 [1098.3-1817.8] 10.8 19.5 866 [633.2-
1184.3] 
13.2 25 547 [357.8-836.2] 8.4 14.5 
Guinea-Bissau 127 [68.3-236.1] 6.7 12 85 [44.0-164.1] 9.1 17.5 42 [6.5-269.7] 4.3 7.4 
Guyana 20 [12.2-32.7] 2.6 2.8 10 [5.0-20.0] 2.5 2.8 10 [5.0-20.0] 2.6 2.7 
Haiti 653 [539.3-790.6] 5.9 7.8 347 [285.0-
422.5] 
6.3 9.1 306 [135.9-689.2] 5.4 6.6 
Honduras 378 [320.9-445.2] 4 5.4 275 [218.2-
346.6] 
5.9 8.2 103 [81.7-129.8] 2.2 2.9 
Hungary 920 [829.5-1020.4] 9.5 4.4 628 [556.7-
708.5] 
13.6 7.3 292 [238.6-357.4] 5.8 2.1 
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Iceland 24 [16.9-34.1] 7.1 3.5 17 [9.9-29.3] 10 5.1 7 [4.4-11.1] 4.2 2 
India 25 627 [24053.8-
27303.2] 
1.9 2 17 548 [16268.1-
18928.7] 
2.5 2.8 8 079 [7196.8-
9069.3] 
1.2 1.3 
Indonesia 18 148 [15797.0-
20848.8] 
6.8 7.5 14 047 [11925.3-
16546.2] 
10.5 12.3 4 101 [3158.3-
5325.1] 
3.1 3.3 
Iran, Islamic 
Republic of 
3 439 [3311.2-3571.7] 4.2 4.7 1 977 [1881.3-
2077.6] 
4.8 5.2 1 462 [1378.8-
1550.2] 
3.6 4.1 
Iraq 538 [472.1-613.1] 1.4 2.7 279 [233.5-
333.4] 
1.4 3.1 259 [213.7-313.9] 1.3 2.3 
Ireland 380 [326.5-442.3] 7.9 4 245 [190.8-
314.6] 
10.3 5.7 135 [111.3-163.8] 5.6 2.5 
Israel 397 [342.9-459.6] 4.7 3 234 [201.5-
271.7] 
5.6 4.1 163 [96.1-276.6] 3.8 2 
Italy 10 535 [10214.5-
10865.6] 
17.8 5.7 7 127 [6846.9-
7418.6] 
24.6 9.2 3 408 [3246.8-
3577.2] 
11.2 2.7 
Jamaica 103 [81.0-130.9] 3.6 2.7 54 [39.1-74.6] 3.7 2.9 49 [34.3-70.1] 3.4 2.6 
Japan 28 986 [28306.8-
29681.5] 
22.8 5.4 18 539 [17987.1-
19107.9] 
29.9 8.6 10 447 [10055.0-
10854.2] 
16 2.7 
Jordan 178 [135.6-233.6] 1.8 2.9 95 [66.8-135.1] 1.9 3.3 83 [54.2-127.2] 1.7 2.6 
Kazakhstan 989 [920.0-1063.2] 5.4 5 605 [551.7-
663.4] 
6.8 7.6 384 [341.7-431.6] 4 3.3 
Kenya 1 331 [1004.0-1764.6] 2.6 5.3 752 [527.0-
1073.0] 
3 6.2 579 [364.4-920.1] 2.3 4.4 
Korea, 
Democratic 
Republic of 
5 246 [4891.0-5626.7] 20.5 15 3 498 [3194.0-
3830.9] 
27.9 23.5 1 748 [1566.0-
1951.2] 
13.4 8 
Korea, 
Republic of 
12 122 [11758.6-
12496.6] 
23.7 11.8 8 819 [8516.9-
9131.8] 
34.5 19.5 3 303 [3102.9-
3516.0] 
12.9 5.2 
Kuwait 114 [84.2-154.3] 2.7 5 82 [57.5-116.9] 3.4 6 32 [18.2-56.2] 1.8 3.6 
Kyrgyzstan 415 [351.0-490.7] 6.8 8.7 252 [199.1-
319.0] 
8.3 12.2 163 [128.4-206.9] 5.3 6 
Lao People's 
Democratic 
Republic 
1 032 [571.0-1865.1] 14.8 22.4 713 [353.0-
1440.0] 
20.5 33.4 319 [106.5-955.3] 9.1 13 
Latvia 138 [113.6-167.6] 7.2 3.1 87 [69.5-108.9] 9.8 5.3 51 [34.1-76.2] 4.9 1.6 
Lebanon 216 [172.5-270.5] 3.5 3 127 [94.6-170.5] 4.2 3.5 89 [62.8-126.1] 2.9 2.5 
Lesotho 67 [39.2-114.6] 3 4.4 41 [20.8-80.9] 3.7 6.6 26 [10.8-62.5] 2.2 3 
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Liberia 422 [227.0-784.4] 8.7 15.4 254 [131.6-
490.2] 
10.4 19.2 168 [26.2-1079.0] 7 11.9 
Libya 147 [93.6-230.8] 2.3 3.3 71 [39.0-129.1] 2.2 3.4 76 [38.2-151.0] 2.4 3.1 
Lithuania 222 [181.4-271.7] 7.7 3.3 136 [104.8-
176.5] 
10.3 5.5 86 [62.5-118.4] 5.5 1.8 
Luxembourg 53 [39.1-71.9] 9 4.4 36 [24.8-52.3] 12.1 6.5 17 [10.0-28.8] 5.8 2.5 
Madagascar 908 [474.3-1738.4] 3.5 6 586 [252.9-
1357.6] 
4.5 8.5 322 [115.7-896.4] 2.4 3.8 
Malawi 312 [163.0-597.3] 1.6 2.5 185 [79.9-428.6] 1.9 2.9 127 [45.6-353.5] 1.3 2 
Malaysia 1 933 [1760.2-2122.7] 6 6.3 1 467 [1315.9-
1635.5] 
8.9 9.6 466 [387.6-560.3] 3 3 
Maldives 26 [25.8-26.2] 5.9 8.2 21 [20.8-21.2] 8.3 12.1 5 [4.9-5.1] 2.6 3.7 
Mali 545 [416.8-712.6] 2.9 5.9 402 [295.6-
546.7] 
4.2 9.7 143 [82.6-247.5] 1.5 2.7 
Malta 24 [15.5-37.2] 5.6 2.4 16 [9.2-27.9] 7.4 3.6 8 [3.9-16.4] 3.7 1.1 
Mauritania 326 [175.4-606.0] 7.2 11.5 224 [116.1-
432.3] 
9.8 16.9 102 [15.9-655.1] 4.5 6.7 
Mauritius 53 [38.9-72.1] 4.2 2.7 27 [17.6-41.4] 4.3 2.9 26 [16.7-40.6] 4.1 2.4 
Mexico 6 868 [6578.5-7170.2] 5.3 5.1 3 361 [3175.3-
3557.5] 
5.2 5.3 3 507 [3283.0-
3746.3] 
5.3 4.9 
Mongolia 1 773 [1671.3-1880.9] 56.8 75.4 1 067 [988.2-
1152.0] 
69.1 98.4 706 [643.5-774.6] 44.7 56.8 
Montenegro 52 [36.6-74.0] 8.3 3.9 33 [21.1-51.7] 10.6 5.7 19 [10.8-33.5] 6 2.5 
Morocco 411 [270.9-623.6] 1.1 1.1 236 [135.7-
410.4] 
1.3 1.3 175 [92.8-330.0] 0.96 0.9 
Mozambique 1 173 [905.2-1520.0] 3.8 6.7 700 [499.2-
981.6] 
4.7 9.4 473 [316.0-708.1] 3 4.7 
Myanmar 5 360 [2965.8-9687.1] 10 10.1 3 571 [1768.1-
7212.3] 
13.6 14.7 1 789 [597.4-
5357.6] 
6.5 6.3 
Namibia 47 [27.5-80.4] 1.8 2.9 31 [15.7-61.1] 2.5 4.2 16 [6.7-38.4] 1.2 1.8 
Nepal 260 [181.6-372.2] 0.88 1 154 [97.9-242.2] 1.1 1.3 106 [58.8-191.0] 0.7 0.8 
New Zealand 353 [292.6-425.9] 7.4 3.9 264 [192.7-
361.7] 
11.3 6.4 89 [70.2-112.9] 3.7 1.7 
Nicaragua 533 [457.3-621.2] 8.5 9.9 290 [240.1-
350.3] 
9.4 12.3 243 [187.1-315.7] 7.6 8 
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Niger 759 [481.0-1197.7] 3.4 7.2 590 [345.9-
1006.5] 
5.3 11.5 169 [70.3-406.1] 1.5 3 
Nigeria 5 154 [3920.8-6775.0] 2.6 5.1 3 192 [2300.6-
4428.9] 
3.2 6.1 1 962 [1193.5-
3225.3] 
2 4.2 
Norway 328 [276.8-388.6] 6.1 2.9 220 [179.6-
269.5] 
8.1 4.2 108 [79.3-147.1] 4.1 1.7 
Oman 111 [72.5-170.0] 2.3 4.3 86 [50.9-145.2] 2.7 5.6 25 [12.0-52.2] 1.5 2.6 
Pakistan 4 222 [3585.2-4971.9] 2.1 3 2 608 [2130.5-
3192.6] 
2.5 3.6 1 614 [1222.5-
2130.8] 
1.7 2.2 
Panama 238 [194.3-291.5] 5.7 4.6 112 [84.5-148.5] 5.4 4.7 126 [94.1-168.7] 6.1 4.5 
Papua New 
Guinea 
635 [373.9-1078.4] 7.5 10.9 354 [188.2-
665.8] 
8.3 12.5 281 [106.4-742.2] 6.8 9.4 
Paraguay 182 [136.9-242.0] 2.6 2.9 114 [78.2-166.2] 3.3 3.7 68 [44.0-105.0] 2 2.1 
Peru 2 239 [2074.3-2416.8] 6.9 6.3 1 057 [948.1-
1178.4] 
6.5 6.5 1 182 [1061.6-
1316.1] 
7.3 6.2 
Philippines 9 485 [8937.5-10066.0] 8.9 11.4 6 776 [6312.7-
7273.3] 
12.6 17.7 2 709 [2428.3-
3022.2] 
5.1 6 
Poland 2 230 [2092.9-2376.1] 5.9 2.7 1 305 [1194.3-
1426.0] 
7.1 3.9 925 [844.7-
1013.0] 
4.7 1.7 
Portugal 1 372 [1217.2-1546.5] 13.3 5.2 980 [840.0-
1143.3] 
20.1 8.9 392 [324.1-474.1] 7.2 2.1 
Puerto Rico 375 [327.9-428.9] 10.2 5.3 249 [207.0-
299.5] 
14.2 8.5 126 [103.7-153.2] 6.6 2.8 
Qatar 40 [29.0-55.2] 1.5 4 35 [24.3-50.4] 1.7 5.6 5 [2.6-9.6] 0.74 1.8 
Republic of 
Moldova 
700 [601.9-814.1] 17.3 11.2 448 [372.8-
538.4] 
23.1 17.3 252 [193.4-328.4] 12 6.7 
Romania 3 141 [2976.7-3314.4] 16 7.5 2 003 [1869.4-
2146.1] 
21.1 11.3 1 138 [1044.6-
1239.8] 
11.3 4.4 
Russian 
Federation 
11 192 [10886.5-
11506.1] 
7.8 4.1 6 432 [6187.1-
6686.6] 
9.6 6.4 4 760 [4575.8-
4951.6] 
6.2 2.6 
Rwanda 704 [463.7-1068.9] 5.6 10.2 457 [271.0-
770.7] 
7.5 14.9 247 [123.3-494.8] 3.9 6.5 
Saint Lucia 4 [2.6-6.2] 2.2 1.1 3 [1.8-5.0] 3.4 2 1 [0.40-2.4] 1.1 0.34 
Samoa 7 [3.0-16.3] 3.5 4.8 5 [1.8-13.6] 4.9 7.1 2 [0.40-9.7] 2.1 2.6 
Sao Tome and 
Principe 
8 [3.8-16.8] 3.8 8.3 7 [3.2-15.4] 6.7 14.8 1 [0.10-9.2] 0.95 2.6 
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Saudi Arabia 852 [693.0-1047.5] 2.5 4.2 636 [499.2-
810.3] 
3.3 5.8 216 [145.4-320.9] 1.5 2.4 
Senegal 1 083 [582.6-2013.1] 6.6 12.6 679 [351.8-
1310.5] 
8.5 18 404 [62.9-2594.7] 4.9 8.5 
Serbia 892 [806.1-987.0] 10.2 4.7 515 [449.0-
590.7] 
12 6.3 377 [324.4-438.1] 8.4 3.5 
Sierra Leone 374 [337.3-414.7] 4.8 9.5 225 [199.0-
254.3] 
5.9 11.9 149 [123.0-180.5] 3.8 7.2 
Singapore 1 298 [1199.2-1405.0] 22.4 11.4 924 [840.8-
1015.5] 
32.3 17.7 374 [323.3-432.6] 12.8 5.7 
Slovakia 473 [421.0-531.4] 8.7 4.3 302 [265.6-
343.4] 
11.4 6.7 171 [125.8-232.4] 6.1 2.5 
Slovenia 268 [234.6-306.2] 12.9 5 175 [148.3-
206.6] 
16.9 7.6 93 [74.4-116.3] 8.9 2.6 
Solomon 
Islands 
55 [32.3-93.6] 8.8 13.7 43 [22.8-81.1] 13.6 20.7 12 [4.5-31.8] 3.9 6.7 
Somalia 241 [125.9-461.4] 1.6 3.3 123 [53.1-285.0] 1.6 3.5 118 [42.4-328.5] 1.5 3.2 
South Africa 2 388 [2231.2-2555.8] 4.2 4.8 1 484 [1362.9-
1615.9] 
5.3 7.2 904 [807.8-
1011.6] 
3.1 3.1 
South Sudan 406 [212.1-777.3] 3.1 5.2 259 [111.8-
600.0] 
4 6.8 147 [52.8-409.2] 2.3 3.7 
Spain 5 569 [5349.6-5797.4] 12 4.7 3 872 [3693.9-
4058.7] 
17 7.6 1 697 [1571.0-
1833.0] 
7.2 2 
Sri Lanka 614 [497.3-758.2] 2.9 2.2 403 [317.2-
512.0] 
4 3.1 211 [135.1-329.6] 1.9 1.4 
Sudan 906 [610.2-1345.2] 2.2 3.7 560 [343.7-
912.4] 
2.7 4.7 346 [176.4-678.6] 1.7 2.7 
Suriname 43 [30.1-61.4] 7.6 7.1 26 [16.5-41.1] 9.1 9.7 17 [9.6-30.1] 6 4.9 
Sweden 785 [709.2-868.9] 7.9 3.1 519 [456.4-
590.2] 
10.4 4.5 266 [225.5-313.8] 5.3 1.8 
Switzerland 875 [764.9-1001.0] 10.2 4.1 567 [486.7-
660.6] 
13.4 5.8 308 [232.0-408.8] 7.1 2.6 
Syrian Arab 
Republic 
380 [208.6-692.2] 2.1 3 198 [100.1-
391.5] 
2.1 3.4 182 [51.6-641.8] 2 2.6 
Tajikistan 253 [210.7-303.8] 2.8 4.4 153 [121.2-
193.1] 
3.3 5.5 100 [74.3-134.6] 2.2 3.4 
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Tanzania, 
United 
Republic of 
1 516 [1028.7-2234.2] 2.6 5 1 146 [714.5-
1838.0] 
3.9 8.2 370 [187.6-729.7] 1.2 2.2 
Thailand 23 154 [22448.8-
23881.3] 
33.5 20.9 16 284 [15696.9-
16893.1] 
48.3 32.3 6 870 [6486.9-
7275.7] 
19.4 11.1 
The former 
Yugoslav 
Republic of 
Macedonia 
187 [132.3-264.4] 9 5 122 [78.2-190.3] 11.7 7.1 65 [37.4-113.0] 6.2 3.1 
The 
Netherlands 
1 044 [966.3-1127.9] 6.1 2.5 648 [593.2-
707.8] 
7.6 3.3 396 [334.6-468.7] 4.6 1.7 
The Republic 
of the Gambia 
343 [288.1-408.4] 15.9 26.2 267 [218.6-
326.1] 
24.9 41.1 76 [53.2-108.6] 7 12.4 
Timor-Leste 38 [21.0-68.7] 2.9 5.3 27 [13.4-54.5] 4 7.4 11 [3.7-32.9] 1.7 3.2 
Togo 310 [279.7-343.6] 3.9 6.9 210 [185.7-
237.5] 
5.3 9.8 100 [82.8-120.7] 2.5 4.2 
Trinidad and 
Tobago 
63 [46.0-86.2] 4.6 3.2 34 [22.1-52.3] 5 3.7 29 [18.4-45.8] 4.2 2.7 
Tunisia 356 [246.3-514.5] 3.1 2.6 147 [91.2-237.0] 2.6 2.3 209 [117.2-372.7] 3.5 2.8 
Turkey 4 307 [4119.8-4502.7] 5.3 4.4 2 747 [2626.6-
2872.9] 
6.8 6.5 1 560 [1110.5-
2191.5] 
3.8 2.7 
Turkmenistan 262 [226.7-302.8] 4.5 5.6 161 [133.8-
193.8] 
5.6 7.6 101 [80.1-127.3] 3.4 3.9 
Uganda 1 552 [1169.7-2059.3] 3.5 6.7 947 [654.0-
1371.2] 
4.3 8.8 605 [390.3-937.8] 2.7 5.1 
Ukraine 2 256 [2102.7-2420.5] 5.1 2.7 1 271 [1159.5-
1393.2] 
6.2 3.9 985 [882.8-
1099.1] 
4.2 1.8 
United Arab 
Emirates 
96 [73.6-125.2] 1 4.2 61 [43.8-84.9] 0.89 4.2 35 [22.4-54.6] 1.3 4.2 
United 
Kingdom 
6 836 [6586.4-7095.1] 10.3 4 4 042 [3845.3-
4248.8] 
12.3 5.3 2 794 [2642.3-
2954.4] 
8.3 2.8 
United States of 
America 
30 485 [29839.9-
31144.1] 
9.3 4.9 20 564 [19973.4-
21172.1] 
12.7 7.2 9 921 [9613.4-
10238.4] 
6 2.8 
Uruguay 131 [103.7-165.5] 3.8 2.1 80 [55.1-116.1] 4.8 3.1 51 [37.7-69.0] 2.8 1.3 
Uzbekistan 1 210 [1066.3-1373.1] 3.7 4.7 660 [554.6-
785.5] 
4.1 5.5 550 [457.5-661.1] 3.4 4 
Vanuatu 28 [16.5-47.5] 9.9 13.1 22 [11.7-41.4] 15.4 20.2 6 [2.3-15.8] 4.3 6.2 
Venezuela, 
Bolivarian 
Republic of 
1 152 [1031.0-1287.1] 3.6 3.5 621 [521.2-
739.9] 
3.9 4.2 531 [460.1-612.8] 3.3 2.9 
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Viet Nam 25 404 [23442.7-
27529.3] 
26.3 23.2 19 708 [17974.3-
21608.9] 
41.3 39.1 5 696 [4832.2-
6714.2] 
11.7 9.4 
Yemen 595 [486.6-727.6] 2.1 4.3 396 [307.4-
510.2] 
2.7 6.2 199 [142.9-277.1] 1.4 2.6 
Zambia 173 [95.5-313.4] 0.98 2.1 101 [47.0-217.2] 1.2 2.7 72 [28.1-184.6] 0.81 1.5 
Zimbabwe 580 [455.7-738.1] 3.4 7 324 [237.8-
441.5] 
3.9 8.8 256 [174.3-376.1] 3 5.6 
World 781 631 [737605.0-
828285.0] 
10.2 8.5 548 375 [511583.0-
587813.0] 
14.2 12.7 233 256 [209922.0-
259184.0] 
6.2 4.6 
 
 
 
 
 
Tab. SIII. Cancer incidence and mortality data: sources and methods by country. 
Incidence Method 
1 National (or local with coverage greater than 50%) rates projected to 2018  
2a Most recent rates from a single registry applied to 2018 population  
2b Weighted/simple average of the most recent local rates applied to 2018 population  
3a 
Estimated from national mortality estimates by modelling, using mortality:incidence ratios 
derived from country-specific cancer registry data 
3b 
Estimated from national mortality estimates by modelling, using mortality:incidence ratios 
derived from cancer registry data in neighbouring countries 
4 "All sites" estimates from neighbouring countries partitioned using frequency data 
9 No data: the rates are those of neighbouring countries or registries in the same area  
  
Mortality  
1 National rates projected to 2018  
2a Most recent rates from one source applied to 2018 population  
2b Weighted/simple average of the most recent local rates applied to 2018 population  
3 
Estimated from national incidence estimates by modelling, using incidence: mortality 
ratios derived from cancer registry data in neighbouring countries 
9 No data: the rates are those of neighbouring countries in the same area  
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Tab. SIV. The method used in each country to calculate the incidence and attenuation of 
cancer in Global Cancer Observatory in 2018. 
Incidence Mortality 
Country Source Method Source Method 
Eastern Africa         
Burundi No data 9 No data 3 
Comoros No data 9 No data 3 
Djibouti No data 9 No data 3 
Eritrea No data 9 No data 3 
Ethiopia Local 2a No data 3 
France, Reunion National 2a National (WHO) 1 
Kenya Local 2b No data 3 
Madagascar No data 9 No data 3 
Malawi Local 2a No data 3 
Mauritius National 1 National (WHO) 1 
Mozambique Local 2b No data 3 
Rwanda Local 4 No data 3 
Somalia No data 9 No data 3 
South Sudan No data 9 No data 3 
Tanzania Local 2b No data 3 
Uganda Local 2b No data 3 
Zambia Local 2a No data 3 
Zimbabwe Local 2b No data 3 
Middle Africa         
Angola No data 9 No data 3 
Cameroon Local 2a No data 3 
Central African Republic No data 9 No data 3 
Chad No data 9 No data 3 
Congo  Local 2a No data 3 
Congo, Democratic Republic of   No data 9 No data 3 
Equatorial Guinea No data 9 No data 3 
Gabon No data 4 No data 3 
Northern Africa         
Algeria Local 2b No data 3 
Egypt Local 2b National (WHO) 3 
Libya Local 2a No data 3 
Morocco Local 2b National (WHO) 3 
Sudan Local 2b No data 3 
Tunisia Local 2b National (WHO) 3 
Southern Africa         
Botswana National 1 No data 3 
Lesotho No data 9 No data 3 
Namibia National 2a No data 3 
South African Republic No data 3b National (WHO) 1 
Swaziland National 2a No data 3 
Western Africa         
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Cape Verde No data 3b National (WHO) 2a 
Benin Local 2a No data 3 
Burkina Faso Local 9 No data 3 
Cote d'Ivoire Local 2a No data 3 
Ghana Local 4 No data 3 
Guinea Local 2a No data 3 
Guinea-Bissau No data 9 No data 3 
Liberia No data 9 No data 3 
Mali Local 2a No data 3 
Mauritania No data 9 No data 3 
Niger Local 2a No data 3 
Nigeria Local 2b No data 3 
Sao Tome and Principe  No data 3b National (WHO) 2a 
Senegal No data 9 No data 3 
Sierra Leone No data 4 No data 3 
The Gambia National 1 No data 3 
Togo Local 4 No data 3 
Caribbean         
Bahamas No data 3b National (WHO) 1 
Barbados No data 3b National (WHO) 1 
Cuba Local 3b National (WHO) 1 
Dominican Republic No data 3b National (WHO) 1 
France, Guadeloupe National 1 National(WHO) 1 
France, Martinique National 1 National(WHO) 1 
Haiti No data 3b National (WHO) 2a 
Jamaica Local 3b National (WHO) 1 
Puerto Rico National 1 National (WHO) 1 
Saint Lucia No data 3b National (WHO) 1 
Trinidad and Tobago No data 3b National (WHO) 1 
Central America         
Belize No data 3b National (WHO) 2a 
Costa Rica National 1 National (WHO) 1 
El Salvador No data 3b National (WHO) 1 
Guatemala No data 3b National (WHO) 1 
Honduras Local 2a National (WHO) 2a 
Mexico No data 3b National (WHO) 1 
Nicaragua No data 3b National (WHO) 1 
Panama No data 3b National (WHO) 1 
South America         
Argentina Local 3a National (WHO) 1 
Bolivia Local 3b National (WHO) 2a 
Brazil Local 3a National (WHO) 1 
Chile Local 3a National (WHO) 1 
Colombia Local 3a National (WHO) 1 
Ecuador Local 3a National (WHO) 1 
French Guiana National 1 National(WHO) 1 
Guyana No data 3b National (WHO) 1 
Paraguay No data 3b National (WHO) 1 
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Peru Local 3a National (WHO) 1 
Suriname No data 3b National (WHO) 1 
Uruguay National 1 National (WHO) 1 
Venezuela No data 3b National (WHO) 1 
Northern America         
Canada Local 1 National (WHO) 1 
United States of America National 1 National (WHO) 1 
Eastern Asia         
China Local 2b Local 2b 
Japan Local 3a National (WHO) 1 
Korea, Democratic Republic of No data 9 No data 9 
Korea, Republic of National 1 National (WHO) 1 
Mongolia National 2a National 2a 
South-Eastern Asia         
Brunei Darussalam National 2a National (WHO) 2a 
Cambodia No data 9 No data 3 
Indonesia National 4 No data 3 
Lao People's Democratic 
Republic No data 9 No data 3 
Malaysia Local 2b National (WHO) 3 
Myanmar No data 9 No data 3 
Philippines Local 2b National (WHO) 3 
Singapore National 1 National (WHO) 2a 
Thailand Local 2b National (WHO) 3 
Timor Leste No data 9 No data 3 
Viet Nam Local 2b National (Survey) 3 
South Central Asia         
Afghanistan No data 9 No data 3 
Bangladesh No data 9 No data 3 
Bhutan 
National 
(pathology-based 
register) 
2a No data 3 
India Local 2b Regional 3 
Iran, Islamic Republic of Local 2b National (WHO) 2a 
Kazakhstan National 2a National (WHO) 2a 
Kyrgyzstan Local 3b National (WHO) 1 
Maldives No data 9 No data 9 
Nepal Local 4 No data 3 
Pakistan Local 2b No data 3 
Sri Lanka National 1 National (WHO) 3 
Tajikistan No data 3b 
National (WHO)  
(ICD-9 limited 
sites). 
2a 
Turkmenistan No data 3b 
National (WHO)  
(ICD-10 limited 
sites). 
1 
Uzbekistan National 2a National (WHO) 1 
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Western Asia         
Azerbaijan National 2a National (WHO) 3 
Armenia No data 3b National (WHO) 1 
Bahrain National 1 National (WHO) 3 
Georgia No data 3b National (WHO) 1 
Iraq National 2a No data 3 
Israel National 1 National (WHO) 1 
Jordan National 1 National (WHO) 3 
Kuwait National 1 National (WHO) 3 
Lebanon National 2a No data 3 
Oman National 1 National (WHO) 3 
Palestine No data 9 National (WHO) 3 
Qatar National  2a National (WHO) 3 
Saudi Arabia National 1 National (WHO) 3 
Syrian Arab Republic No data 9 No data 3 
Turkey Local 2b National (WHO) 2a 
United Arab Emirates National 2a No data 3 
Yemen Local 2b No data 3 
Eastern Europe         
Belarus National 1 National (WHO) 1 
Bulgaria National 1 
National (WHO, 
ICD-10 limited 
sites). 
2a 
Czech Republic National 1 National (WHO) 1 
Hungary No data 3b National (WHO) 1 
Moldova No data 3b National (WHO) 1 
Poland Local 3a National (WHO) 1 
Romania Local 3b National (WHO) 1 
Russian Federation National 1 National (WHO, ICD-10 limited sites) 1 
Slovakia National 2a National (WHO) 1 
Ukraine National 1 National (WHO, ICD-10 limited sites) 1 
Northern Europe         
Denmark National 1 National (WHO) 1 
Estonia National 1 National (WHO) 1 
Finland National 1 National (WHO) 1 
Iceland National 1 National (WHO) 1 
Ireland National 1 National (WHO) 1 
Latvia National 1 National (WHO) 1 
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Lithuania National 1 National (WHO) 1 
Norway National 1 National (WHO) 1 
Sweden National 1 National (WHO) 1 
United Kingdom National 1 National (WHO) 1 
Southern Europe         
Albania No data 3b National (WHO) 1 
Bosnia Herzegovina Local 3a National (WHO) 2a 
Croatia National 1 National (WHO) 1 
Cyprus National 1 National (WHO) 1 
FYR Macedonia No data 3b National (WHO) 1 
Greece No data 3b National (WHO)  1 
Italy Local 3a National (WHO) 1 
Malta National 1 National (WHO) 1 
Montenegro No data 3b National (WHO) 1 
Portugal Local 3a National (WHO) 1 
Serbia Local 3b National (WHO)  1 
Slovenia National 1 National (WHO) 1 
Spain Local 3a National (WHO) 1 
Western Europe         
Austria National 1 National (WHO) 1 
Belgium National 1 National (WHO)  1 
France Local 3a National (WHO) 1 
Germany Local 1 National (WHO) 1 
Luxembourg 
National 
(pathology-based 
register) 
3b National (WHO) 1 
The Netherlands National 1 National (WHO) 1 
Switzerland Local 3a National (WHO) 1 
Australia/New Zealand         
Australia National 1 National (WHO) 1 
New Zealand National 1 National (WHO) 1 
Melanesia         
Fiji No data 3b No data 3 
France, New Caledonia National 2a National (WHO)  2a 
Papua New Guinea Local 9 National 2a 
Solomon Islands No data 9 No data 3 
Vanuatu National 2a No data 3 
Micronesia         
Guam No data 9 National 2a 
Polynesia         
French Polynesia National 2a National 2a 
Samoa No data 9 No data 9 
 
 
